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Abstract 
Initiation of a new round of cell proliferation in eukaryotic cells is associated 
with coordinated transcriptional activation of genes during the G1-to-S 
transition. In the fission yeast Schizosaccharomyces pombe, genes involved 
in DNA replication are tightly regulated by the transcription factor MBF during 
G1/S. Recently, the MBF-associated corepressors Nrm1p and Yox1p were 
shown to have a non-redundant role in a negative feedback loop mechanism 
to repress MBF-dependent transcription outside of G1. Activation of the DNA 
replication checkpoint results in persistent expression of MBF-dependent 
genes. Here we show that in response to DNA replication stress both Yox1p 
and Nrm1p dissociate from MBF at promoters, leading to de-repression of 
MBF targets. Inactivation of Yox1p is an essential part of the checkpoint 
response. Cds1p checkpoint protein kinase-dependent phosphorylation of 
Yox1p promotes its dissociation from the MBF transcription factor. We 
establish that phosphorylation of Yox1p at Ser114 and Thr115 is required for 
maximal checkpoint-dependent activation of the G1/S cell-cycle transcriptional 
programme. G1/S transcription includes many genes required for replication 
and recovery of stalled replication forks. Although persistent expression of the 
G1/S transcriptional programme is an important part of the DNA replication 
checkpoint response we show that constitutive expression of the same group 
of genes outside of G1 and S is detrimental for cells undergoing normal cell 
cycle progression. Cells abrogated for nrm1+ and yox1+ experience 
increased genomic instability. We demonstrate that a delicate balance exists 
between levels of DNA replication initiation factors and CDK activity in these 
cells. Disruption of this balance induces further genome instability, a hallmark 
of cancer development.   
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1.1 – The cell cycle of the model organism S. pombe 
 
1.1.1 – Temporal and spatial organisation of the cell cycle of S. pombe 
In order to divide cells must go through the mitotic cell cycle during which 
they replicate their DNA and separate their replicated chromosomes into two 
separate cells. The cell division cycle is an extremely important process that 
is linked to a wide range of physiologic (e.g. cell growth, embryonic 
development, tissue hyperplasia) and pathologic processes (e.g. cancer, 
Alzheimer’s disease, some cardiovascular diseases) (Zhivotovsky and 
Orrenius, 2010). As observed for most eukaryotic cells, the mitotic or cell-
division cycle of the fission yeast Schizosaccharomyces pombe is divided 
into two major periods known as interphase and mitotic phase (Figure 1.1A). 
Interphase, the stage whereby cells grow, replicate their DNA and prepare to 
undergo mitosis is further divided into three phases, gap phase 1 (G1), DNA 
synthesis (S) and gap-phase 2 (G2). The mitotic phase encompasses a 
process known as mitosis (M), the mechanism through which cells segregate 
their duplicated chromosomes into two daughter cells (Morgan, 2007). Cells 
resulting from mitosis are identical to each other and to their parental cell as 
they share a common genetic background. Mitosis can be further 
differentiated into five subphases: prophase, prometaphase, metaphase, 
anaphase and telophase. Once cells divide their nucleus and remaining 
cytoplasmic components into two identical cells, a mechanism termed 
cytokinesis separates the newly formed cells, which are then ready to enter a 
new cycle (Tyson and Novak, 2008). 
Vegetative cycle - Unlike mammalian and other fungi cells such as 
Saccharomyces cerevisiae cells, which spend most of their time in G1 phase, 
wild-type S. pombe cells exist mainly as G2 cells and they can take up to 3h 
to complete a full cell cycle (Gómez and Forsburg 2004). As a result of the 
short G1 period in fission yeast cytokinesis is not completed until around the 
end of S phase. A direct consequence of this is that S. pombe haploid cells in 
S phase are binucleate cells with 2C-4C DNA content. Once a binucleate S 
phase cell divides by medial fission each replicating nucleus is packaged into 
a separate cell surrounded by a distinct cell wall and at the end of S phase 
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cells emerge as 2C DNA content G2 phase cells, ready to grow by polarised 
tip elongation, before entering another round of mitosis (Figure 1.1A). Given 
their extremely short G1 and S phases, fission yeast cells exert a high 
degree of control over their cell cycle, nutrition and cell growth at the G2/M 
transition (Forsburg and Nurse, 1991) (Egel, 2004). 
 
Figure 1.1 – The life cycle of S. pombe 
(A) Wild type vegetative S. pombe cells undergoing exponential growth spend 70% 
of their cell cycle in G2 and 10% in each of the remaining phases. Note the 
equivalent to the mammalian restriction point, START, and septation, immediately 
before or during S phase, respectively. The nuclear envelope of S. pombe does not 
disassemble during mitosis. Instead, the microtubules necessary to form the mitotic 
spindle invade the intranuclear space. (B) In nitrogen-poor environments, haploid S. 
pombe cells can either enter stationary phase (small G0 phase cells) or pair up with 
a partner of opposite mating type and produce a resistant tetrad ascus. Each ascus 
segregates its spores in a 2:2 ratio fashion. Thus, fission yeast is easy to manipulate 
using Mendelian and classic genetics. In glucose deprived environments cells arrest 
in G2 1.  
 
Reproductive cycle - The life cycle of this unicellular eukaryote alternates 
between vegetative asexual division and sexual reproduction stages, 
depending upon nutrient availability. In carbon- and nitrogen-rich 
environments S. pombe cells are fast replicating haploid rod shape cells that 
divide by asexual division. When nutrients are in short supply, in particular 
that of nitrogen sources, and partners of the opposite mating type (termed                                                         
1 Adapted from Gómez and Forsburg, 2004. 
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minus M or plus P) are present, two cells pair up and fuse with each other 
through a process known as conjugation (Figure 1.1B). The organism enters 
its sexual reproductive cycle. Conjugation is followed by nuclear fusion 
(karyogamy) and transient formation of a diploid zygote that following a round 
of meiosis develops into an elongated tetrad ascus composed of four haploid 
nuclei, the ascospores. When nutrients are replenished each dormant 
ascospore has the ability to germinate and enter the vegetative cycle at G1 
phase (Egel, 2004). 
1.1.2 –Regulation of cell cycle progression 
In the recent past, much effort has been made to understand the molecular 
and biochemical mechanisms underlying the cyclic nature of the cell cycle. 
The extraordinary coordination of events that occur throughout the cell cycle 
is at present explained via the “clock + checkpoint” theory. The first part of 
this model, the clock, is understood as the temporal “cyclic sequence of 
states” that occur during the cell cycle and the second part, the checkpoints, 
as the processes necessary to ensure that the cell cycle progresses 
faultlessly (Tyson and Novak, 2008) (see section 1.2 and 1.5).  
The master regulators governing progression through the different stages of 
the cell cycle, the Cyclin Dependent Kinases (CDKs), were first discovered 
through the pioneering work of three independent scientists who have won 
the Nobel Prize in Physiology or Medicine: Paul Nurse (in S. pombe), Tim 
Hunt (in sea urchin and clam eggs) and Leland H. Hartwell (in S. 
cerevisiae)2. CDKs are part of a complex regulatory network that is highly 
conserved across species and consists of many biochemical molecules 
including CDKs, cyclins, CDK inhibitors (CDKIs), CDK-activating kinases and 
phosphatases (CAKs) (Schafer, 1998). It is the periodic accumulation, 
inhibition and proteolytic destruction of these proteins that confers the cell 
cycle with its cyclic quality.  
Mammalian cells present various CDK protein kinases and cyclins, however,                                                         
2 "The Nobel Prize in Physiology or Medicine 2001". Nobelprize.org. 3 Jul 
2012 http://www.nobelprize.org/nobel_prizes/medicine/laureates/2001/ 
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in S. pombe only one CDK, Cdk1 (also known as Cdc2), capable of driving 
both G1/S and G2/M transitions, and four cyclins, Puc1, Cig1, Cig2 and 
Cdc13, have been identified. Cdk1 is the master regulator of the fission yeast 
cell cycle (Nurse et al., 1976). 
 
Figure 1.2 – Key regulators of the mitotic cycle of S. pombe 
Progression through the vegetative cell cycle of S. pombe is secured by a unique 
Cdk protein, Cdk1. Cdk1 binds to cyclins Puc1, Cig1, Cig2 and Cdc13 to promote, 
passage through G1, G1/S, S and M phases, respectively. Mitosis is a highly 
regulated event. In order to ensure the correct timing of M, the Cdk1-Cdc13 complex 
is the target of an intricate regulatory phosphorylation system. Inactivation of Cdk1-
Cdc13 by Y15 phosphorylation via the CDKI Wee1 during G1 and G2 phases, 
respectively, plays a role of extreme importance in preventing early entry into 
mitosis. Note that Rum1 can also inhibit Cdk1-Cig2 function outside of S and M 
phases. (B) In order to achieve its activity peak and promote chromosome 
segregation, Cdk1-Cdc13 must suffer both T167 phosphorylation and Y15 
dephosphorylation. Whilst phophorylation at residue T167 is achieved via the CAK 
Mcs6-Mcs2, Y15 dephosphorylation is undertaken by the phosphatase Cdc25. (C) 
Start of a new cycle and entry into G1 requires inactivity of the Cdk1-Cdc13 complex 
which is attained via Rum1-dependent inhibition of Cdk1-Cdc13 and via APC-
dependent destruction of cyclin Cdc13. 
Succinctly, the mitotic cell cycle of S. pombe is thought to be regulated as 
follows (Figure 1.2) Cdk1 binds to cyclin Puc1 to promote mitotic cell division 
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and entry into G1 (Forsburg and Nurse, 1994). Subsequent accumulation 
and binding of Cdk1 to Cig1 during G1/S and then to Cig2 in S, promotes 
DNA replication initiation and cytokinesis (Connolly and Beach, 1994) 
(Mondesert et al., 1996). Then Cdk1 binding to the G2/M cyclin Cdc13 
inhibits re-initiation of DNA synthesis and drives passage into M (Fisher and 
Nurse, 1996). Finally, degradation of Cdc13 via APC-ubiquitin-mediated 
proteolysis and re-accumulation of Puc1 throughout M leads to segregation 
of the sister chromatids, promotes entry into G1 and the beginning of a new 
cycle (Martín-Castellanos et al., 2000). The activity of the various Cdk1-cyclin 
complexes is regulated extensively by phosphorylation. Phosphorylation at 
T167 via the CAKs Mcs6-Mcs2 and Cak1 is crucial for Cdk1 kinase activity, 
whereas Y15 phosphorylation by the CDKIs Wee1 and Mik1 right before M 
inhibits its function. Furthermore, entry into mitosis requires 
dephosphorylation of Cdk1 at Y15 by the phosphatase Cdc25 (Figure 1.2). 
Some of these factors, including CDKIs and cyclins are further regulated by 
E3-mediated ubiquitination and proteasome-dependent proteolysis via either 
or both the APC and SCF. Finally cell cycle regulated transcription is 
required for the timely accumulation of many of the proteins involved, 
including but not limited to the cyclins Cig1 and Cig2, the CDKI Mik1 and 
components of the SCF (Bähler, 2005). 
 
The widely accepted idea is that progression through the cell cycle is driven 
by the formation of complexes of Cdk1 with the different and phase specific 
cyclins described above. Interestingly, a recent study shows that S. pombe 
cells engineered to transcribe Cdk1-Cdc13 as a fused, monomolecular 
molecule, are able to drive their cell cycle almost identical to their wt 
counterparts, in the absence of all the remaining interphase cyclins. This 
suggests that oscillation of a single CDK-mitotic cyclin module is sufficient to 
activate many of the events that characterise the mitotic cell cycle, 
depending upon its activity and abundance status (Coudreuse and Nurse, 
2010). In line with this hypothesis a different study undertaken in mouse 
embryos shows that all interphase Cdks (and possibly all interphase cyclins) 
are likely to play a redundant role in regulating the major cell cycle events, as 
ablation of these molecules does not affect organogenesis and development 
until midgestation (Santamaría et al., 2007). 
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1.2 – Periodic gene expression as a driving force of cell cycle 
progression  
Cell-cycle dependent gene expression (also known as cell-cycle dependent 
waves of transcription) plays an important role in driving the eukaryotic cell 
division cycle. These waves of transcription, activated at different time during 
the cell cycle, encode proteins required for tasks in subsequent phases of the 
cell cycle. Hundreds of genes - 400 to 900, depending on the study - that are 
expressed as a function of cell cycle progression have been identified in 
fission yeast using genome-wide technology (Rustici et al., 2004) (Peng et 
al., 2005) (Oliva et al., 2005) (Marguerat et al., 2006). At least 800 genes 
displaying similar oscillatory behaviour have been reported for S. cerevisiae 
(Spellman et al., 1998). In fission yeast, as in most eukaryotes, periodically 
transcribed genes can be clustered into three main waves, each regulated by 
one or more specific transcription factors: G1/S (DNA replication), regulated 
by the MBF transcription factor complex; G2/M (entry into mitosis) regulated 
by the transcription factors Sep1p, Fkh2p and Mbx1; and M/G1 (exit from 
mitosis) regulated by the Ace2p transcription factor (Bähler, 2005). This 
project focuses on the G1/S wave of transcription in S. pombe, which 
regulation is undertaken by the transcription factor complex MBF. 
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1.3 – The G1/S transcriptional programme in S. pombe 
Once yeast cells commit to the mitotic cell cycle, passing a point in G1 called 
START, DNA synthesis initiation becomes inevitable, irrespective of 
treatment with growth-stimulatory signals (Simanis et al., 1987). Passage 
through START and entry into mitotic S phase in S. pombe, is largely 
dependent on the expression of a group of genes tightly regulated by the 
MluI Cell Cycle Box (MCB) Binding Factor (MBF). 
1.3.1 – The “anatomy” of the MBF transcription factor complex 
The core components of the fission yeast MBF (Figure 1.3A) include two 
homologous DNA-binding, zing-finger proteins termed Res1 (aka Sct1) 
(Tanaka et al., 1992) (Caligiuri and Beach, 1993) and Res2 (aka Sct2) 
(Miyamoto et al., 1994) and the product encoded by the START gene cdc10+ 
(Aves et al., 1985) (Zhu et al., 1997). In budding yeast G1/S transition 
requires the activity of at least two heteromeric transcription factors, the MBF 
and the SBF (Horak et al., 2002). MBF and SBF are each composed of a 
Swi6 molecule (homologous to Cdc10) and one of two DNA-binding partners, 
Mbp1 and Swi4 (homologous to Res2 and Res1, respectively). Although 
there is no sequence or structural homology between the yeasts’ MBF and 
SBF and the E2F family of transcription factors that regulate G1/S 
transcription in mammals, recent data suggests that the mechanism of 
regulation is conserved (Cooper, 2006). As a result, studying G1/S 
transcriptional regulation in yeast may contribute to the understanding of 
G1/S transcription regulation in higher eukaryotes, including humans (de 
Bruin and Wittenberg, 2009).  
It is well established that conditional abrogation of Cdc10 prevents cells from 
entering S phase (Nurse et al., 1976) (Tanaka et al., 1992). Until recently, it 
was thought that MBF-dependent gene transactivation would take place via a 
partially redundant subunit switch mechanism in which Cdc10 would cluster 
independently with either Res1 (Cdc10-Res1 complex) or Res2 (Cdc10-Res2 
complex) in order to regulate, primarily, entry into mitosis or meiosis, 
respectively (Tanaka et al., 1992) (Miyamoto et al., 1994). New data obtained 
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from electrophoretic mobility shift assays (EMSA) and time-course co-
immunoprecipitation (Co-IP) experiments led to the development of an 
alternative model. In this model, Res1 and Res2 are hypothesised to form a 
heterodimer complex and bind constitutively to Cdc10 via their carboxy-
terminal regions and to MCB-containing promoters via their amino-terminal 
ends (Zhu et al., 1997) (Baum et al., 1997) (Whitehall et al., 1999). Thus, 
Cdc10, Res1 and Res2 are thought to regulate G1/S transcription as a single 
integrated complex that switches between an active (during G1) and an 
inactive (outside of G1) state, rather than functioning as two independent 
transcription factor complexes. Four lines of evidence support this model: 1) 
the steady-state transcript and protein levels of Cdc10, Res1 and Res2 
remain constant throughout cell cycle progression, (Figure 1.3B) (Simanis 
and Nurse, 1989) (Whitehall et al., 1999); 2) Res1, Res2 and Cdc10 form a 
high DNA-binding affinity complex, as detected by EMSA (Zhu et al., 1997); 
3) MCB binding by the MBF is detectable in cell extracts deriving from all cell 
cycle phases, although it is only active during G1/S (Reymond et al., 1993) 
(Ayté et al., 1995); 4) the MBF remains constitutively associated to MCB-
containing promoters as demonstrated by chromatin-immunoprecipitation 
(ChIP) analyses (Wuarin et al., 2002).  
MBF regulates the expression of over 40 putative target genes, encoding 
proteins that are predominantly involved in DNA synthesis, DNA repair and 
cell-cycle control (Rustici et al., 2004). The promoter region of this cluster of 
genes is characterised by the presence of one or more cis-acting MCB1 
(ACGCGT) or MCB2 (CGCGACGCGT) elements (Figure 1.3A) that serve as 
the platform for MBF binding (Lowndes et al., 1992). Some very well 
established MBF targets are cdc22+ (Lowndes et al., 1992), cdc18+ (Kelly et 
al., 1993) and cdt1+ (Hofmann and Beach, 1994), which encode the large 
subunit of the ribonucleotide-diphosphate reductase (RNR - a key enzyme in 
the anabolism of deoxyribonucleotides) and two independent replication 
origin licensing factors, respectively (Table 1.1 for a description of the main 
MBF-dependent transcripts). 
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Figure 1.3 – The anatomy of the MBF transcription factor 
(A) Main components of the MBF transcription factor. (B) Expression levels of the 
main components of the MBF and its regulator proteins throughout the cell cycle. 
Adapted from Rustici et al (2004).  
The initial characterization of res1+ and res2+ null mutants revealed a 
downregulation and an upregulation of mRNA levels of cdc18+, cdc22+, 
cdt1+ and cig2+, respectively (Zhu et al., 1997) (Baum et al., 1997). Whilst 
ectopic expression of Res1 enhances expression of cdc18+, cdc22+, cdt1+ 
and cig2+ transcripts, with loss of periodicity, ectopic expression of Res2 
induces a slight repression of the same MBF-target transcripts (Ayté et al., 
1995) (Baum et al., 1997) (Ayté et al., 2001). Taken together, these results 
suggest that Res1 may behave as a positive regulatory subunit of the MBF 
and Res2 as a repressor. Recent evidence has challenged this view, 
suggesting that Res2 may also play a positive and Res1 a negative 
regulatory role in MBF activity for certain targets (Whitehall et al., 1999) 
(Dutta et al., 2008). 
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Table 1-1 - Genes regulated by the transcription factor MBF 
MBF Gene Role and degradation 
 
Cdc18 
 
Replication licensing factor – Mcm2-7 loader; degraded via the SCF in a CDK-
Cig2 dependent manner (Lopez-Girona et al., 1998) (Baum et al., 1998). 
 
Cdt1 
 
Replication licensing factor – Mcm2-7 loader; degraded via the SCF in a Cdt2- 
and Ddb1-dependent manner (Ralph et al., 2006).   
 
Cdc22 
 
Ribonucleoside reductase large subunit 
 
Suc22 
 
Ribonucleoside reductase small subunit 
 
Nrm1 
 
MBF co-repressor degraded via the APC (unpublished data) 
 
Yox1 
 
MBF co-repressor 
 
Cig2 
 
G1/S-specific B-type S-phase cyclin; degraded via the SCF in a Pop1- and 
Pop2-dependent manner (Yamano et al., 2004) 
 
Mrc1 
 
Mediator of checkpoint protein 1 
 
Ams2 
 
Cell cycle regulated GATA-type transcription factor 
 
Mug40/polk 
 
DinB translesion DNA repair polymerase 
 
Psm3 
 
Mitotic cohesin complex subunit 
 
Rhp51 
 
RecA family recombinase  
 
Mik1 
 
Mitotic inhibitor kinase Mik1 
 
Rad21 
 
Mitotic cohesin complex, non-SMC subunit 
 
Ste9 
 
CDK inhibitor 
 
Ssb1 
 
DNA replication factor A subunit 
 
Pfh1 
 
5 prime to 3 prime DNA helicase, involved in DNA recombination and repair 
 
Pol1 
 
DNA polymerase alpha catalytic subunit 
 
Pof3 
 
F-box protein 
Cdt2 WD repeat protein – involved in the degradation of Cdt1 
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1.3.2 – Regulation of MBF transcription  
The mechanism by which MBF-dependent transcription is confined to G1 has 
only recently been established in both S. cerevisiae and S. pombe. In fission 
yeast, MBF activity is modulated by at least four co-factors: the co-activators 
Rep1 and Rep2 and the co-repressors, Nrm1 and Yox1. The role of Rep1 
and Rep2 in regulating periodic expression of MBF targets is still poorly 
understood. Rep1 is necessary for activation of premeiotic DNA synthesis 
and highly induced following nitrogen starvation (Sugiyama et al., 1994). 
Rep2, seems to be required for maximal transcriptional activity during the 
mitotic cell cycle, possibly by mediating inactivation of the repressor Res2, as 
suggested by biochemical and genetic evidence (Nakashima et al., 1995) 
(Baum et al., 1997) (Tahara et al., 1998). However, recent studies have 
uncovered that MBF-mediated mitotic transcription is restricted to the G1 
phase of the cell cycle, mainly, by an auto-regulating negative feedback loop 
involving the products of the MBF targets nrm1+ and yox1+. Nrm1 and Yox1 
regulate normal cell cycle MBF activity via a double non-redundant 
transcriptional repression mechanism (Aligianni et al., 2009). Deletion of 
nrm1+, yox1+ or both results in constitutive elevated levels of MBF-target 
transcripts (de Bruin et al., 2006) (Aligianni et al., 2009). The current view on 
the mechanism governing MBF-dependent cell cycle transcription is as 
follows (Figure 1.4): 1) activation of MBF-dependent transcription results in 
the accumulation of Nrm1 and Yox1 molecules synthesised de novo in late 
G1, resulting in binding and subsequent repression of MBF-dependent 
transcription as cells progress into S-phase 2) Nrm1 and Yox1 remain bound 
to MBF throughout S-, G2- and M-phases to repress MBF activity; 3) as cells 
enter G1, Nrm1 and Yox1 are degraded, relieving transcriptional repression 
of MBF transcripts and allowing DNA synthesis to occur (de Bruin et al., 
2006) (de Bruin et al., 2008) (Aligianni et al., 2009). Together these events 
limit MBF activity to a very short time interval so that activation of genes 
necessary for DNA replication occurs once and only once per cell cycle. The 
mechanisms by which Nrm1 and Yox1 are targeted for destruction during 
entry into interphase or how they induce repression of MCB-containing genes 
remain elusive. Beside its role in normal cell cycle progression Nrm1 has 
also been implicated in the DNA replication checkpoint transcriptional 
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response. In response to DNA replication stress Nrm1 is inactivated via 
phosphorylation by the DNA replication checkpoint kinase Cds1 (de Bruin et 
al., 2008). This results in de-repression of G1/S transcription during the 
checkpoint response. Part of the work described here shows that Yox1 is 
also involved in maintaining the MBF transcription programme in response to 
replication stress.  
 
Figure 1.4 – The regulation of the MBF transcription factor 
Inactivation of MBF-dependent transcription during late S phase of the normal cell 
cycle is dependent on binding of the co-repressors Yox1 and Nrm1 to the core 
components of the MBF transcription factor. MBF-dependent transcription is turned 
OFF during the G1 to S transition by a double non-redundant negative feedback 
mechanism involving Nrm1 and Yox1. 
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1.4 – DNA replication in S. pombe 
Genomic instability is a threat to cell survival and a driving force of human 
diseases, including cancer. To prevent genomic instability cells must 
duplicate their chromosomes once and only once per cell cycle. This requires 
a high degree of coordination and accuracy (Maric and Prioleau, 2010). DNA 
replication is in general a highly conserved mechanism. DNA molecules are 
long polymers of adenine, thymine, guanine and cytosine 
deoxyribonucleotides, arranged as an anti-parallel double helix, with 
phosphate groups facing outwards and bases inwards (Watson and Crick, 
1953). During DNA replication, the double-stranded DNA template unwinds 
at the sites of replication initiation, with the help of the Mcm2-7 
(minichromosome maintenance) helicase. DNA replication undertaken by 
DNA replication polymerases initiates bidirectionally from the replication fork, 
in the 5 prime - 3 prime direction, a process known as elongation. Sites of 
replication initiation are known as origins of replication (ORI) and the 
complex of proteins taking part in this process together with the DNA to 
which they are bound to as the replication fork or the replisome. Whilst 
replication of the leading strand occurs in a linear and continuous fashion, 
due to the energetic requirements of 5 prime - 3 prime synthesis, synthesis of 
the lagging strand occurs via the formation of short discontinuous sections 
called Okazaki fragments (Ge and Blow 2009). Fork speed fluctuates along 
the chromosomes depending on genome primary structure and chromatin 
architecture.   
For the purpose of this report we will focus our attention on the early events 
of replication, the mechanisms of replication initiation. This involves origin 
licensing, the transcriptional programme necessary for DNA replication 
initiation, the role of the cell cycle in regulating replication initiation events 
and the biological consequences of rereplication and endoreplication.  
1.4.1 – DNA replication origins in S. pombe  
DNA replication initiates at regions known as origins of replication (Miyabe et 
al., 2009). Contrary to prokaryotic cells, which present well-defined single 
sites of replication, eukaryote cells have hundreds if not thousands of ORIs 
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that fire asynchronously during S phase (Robinson and Bell, 2005). This 
increase in the number of origins verified in eukaryotes is directly correlated 
to genomic size, as it helps minimise the time necessary for DNA replication 
of larger genomes. 
Although they lack a general recognisable sequence motif, S. pombe origins 
are generally 500-1000bp-long AT-rich regions, located in intergenic 
stretches of the DNA. Based on this feature, 384 potential origins have been 
identified in fission yeast, using genome-wide bioinformatics analysis 
(Segurado et al., 2003). According to a different genome-wide study, S. 
pombe may contain a total of 503 strong and weak putative ORIs 
interspersed every 14kb across the genome and divided into early and late 
origins, depending on the time at which they fire throughout the cell cycle 
(Heichinger et al., 2006).  
Extensive research shows that DNA replication initiation in fission yeast and 
other eukaryotes such as Xenopus laevis and Drosophila melanogaster, is a 
stochastic event (Nishitani and Lygerou, 2002) (Robinson and Bell, 2005). At 
least half of the intergenic stretches have the potential of functioning as an 
ORI, depending on AT average content and length, thus suggesting a rather 
promiscuous DNA binding consensus system. This model diverges from the 
classical replicon model suggested for prokaryotes and budding yeast (Dai et 
al., 2005) (Robinson and Bell, 2005). In line with this data, the fission yeast 
origin of replication complex subunit protein Orc4, which binds ORIs, 
contains nine AT hooks, suggesting a high affinity towards AT-rich lengthy 
regions (Chuang and Kelly, 1999). In this scenario, the greater the AT 
content and the length of a region the greater its binding affinity. However, 
another study, undertaken by Cotobal et al, suggests that stretches as short 
as 30bp can determine an active ORI (Cotobal et al., 2010).  
If the stochastic model view is correct then a problem arises, the “random 
completion problem”. According to this theory, replication of large genomic 
regions with few or no origins may be prone to be missed out by chance, 
resulting in gaps that would take longer than usual to replicate, through 
passive replication arriving from distantly located origins (Sclafani and 
Holzen, 2007). Two solutions have been suggested to resolve this issue: 1) 
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more origins are prepared to fire than those that actually do, a fail safe 
phenomenon known as origin redundancy and 2) there is a mechanism in 
place that ensures a regular and evenly distribution of origins across the 
genome, a model known as “the fixed spacing model” (Jun et al., 2004) 
(Maric and Prioleau, 2010). Origins of replication can be classified into early 
and late firing origins, depending on the time at which they fire during S 
phase. Whereas in budding yeast this temporal initiation programme is 
hereditary (Mantiero et al., 2011), in fission yeast origins that have fired 
during a specific cell cycle do not necessarily fire at the same time in 
subsequent cell cycles. They may not even fire at all until much later (Kim 
and Huberman, 2001) (Legouras et al., 2006). Hence, ORIs in S. pombe are 
stochastic both in space and in time. Furthermore, there seems to be a 
strong correlation between chromatin state/epigenetics and replication 
timing, as transcriptionally active euchromatic regions seem to be replicated 
earlier than inactive heterochromatic stretches of DNA (Sclafani and Holzen, 
2007) (Maric and Prioleau, 2010).  
1.4.2 – Molecular mechanism of DNA replication initiation in S. pombe  
Replication initiation is a highly regulated multistep event divided into three 
main stages (Figure 1.5). Following S phase, origins are in a post-replicative 
state as they are unable to fire and commence replication. It is only after 
return into interphase, during G1, when ubiquitin ligase-dependent 
degradation of cyclins takes place and CDK activity is low and the G1/S 
transcriptional programme is turned ON, that origins become competent and 
get into the pre-replicative state. The origin licensing step involves binding of 
the Mcm2-7 helicase via the licensing factors and MBF-dependent genes 
Cdt1 and Cdc18 (Cdc6 in budding yeast and mammalian cells). This process 
requires low levels of CDK activity, since CDK-dependent phosphorylation 
inhibits this reaction.  The activation step involves pre-replicative complexes 
to be activated by the helicase activator Cdc45 to form the pre-initiation 
complexes. Finally the initiation and licensing inhibition stage, when 
replication initiation and simultaneous inhibition reactions take place, 
prevents ORIs from being relicensed. The process of replication initiation and 
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the factors that bind to ORIs are well conserved across species (Legouras et 
al., 2006). 
 
Figure 1.5 – DNA Replication initiation in S. pombe 
DNA replication initiation is divided into three main stages: 1) licensing, 2) activation 
and 3) initiation and licensing inhibition. Licensing of origins requires the licensing 
factors Cdc18 and Cdt1 to enable the binding of the helicase Mcm2-7 to sites of 
ORC, in late M phase and when CDK activity is low. This step is followed by the 
loading of Cdc45 onto replisomes during activation. Following the activation step, S-
phase-specific CDK and DDK activities activate Cdc45 helicase molecules and 
replication initiates in a bidirectional manner. Once origins have fired the licensing 
factors Cdc18 and Cdt1 are sent for proteolysis in order to prevent re-firing of 
already fired ORIs and hence prevent rereplication. CDK activity is required for 
proteolysis of Cdc18, which occurs via the SCF3. 
In fission yeast, ORIs are constitutively bound throughout the cell cycle by 
the origin recognition complex (ORC), a heteromeric assembly composed of 
six subunits (Orc1 to Orc6).  ORCs preferentially bind to AT-rich stretches of 
DNA, possibly via multiple AT hook domains located in the N-terminus of                                                         
3 Adapted from Legouras et al, 2006. 
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Orc4 (Lygerou and Nurse, 1999). ORCs provide the platform for binding of 
the remaining replication fork proteins onto chromatin. Licensing of post-
replicative origins, during G1, involves the loading of the minichromosome 
maintenance complex (Mcm2-7), a doughnut-like or toroidal macromolecule 
composed of six AAA+ domain-containing lobes surrounding a central cavity 
(Adachi et al., 1997). Biochemical and structural data obtained in yeast, 
bacteria and mammalian cells indicate that this complex may act as the DNA 
replicative helicase, which unwinds DNA during DNA synthesis (You et al., 
1999) (Bell and Dutta, 2002) (Boos et al., 2012), thus, playing a role of 
extreme importance in both the initiation and elongation steps of DNA 
synthesis. Loading of the Mcm2-7 complex onto chromatin is dependent 
upon the AAA+ ATPase activities of the ORC and the licensing factors Cdc18 
and Cdt1 (Mehanna and Diffley, 2012). Following binding of inactive Mcm2-7 
onto ORCs during G1, origins transition from a post-replicative state into a 
pre-replicative state, they are ready to be activated (Legouras et al., 2006).  
In the second step of DNA replication initiation pre-RC complexes are 
transformed into transient pre-initiation complexes (pre-IC) via binding of the 
helicase activator Cdc45/Sld4. Recruitment of Cdc45 initiates Mcm2-7 
helicase activity leading to origins firing in a bidirectional manner and cells 
initiating DNA synthesis. Cdc45 function is regulated by several factors, the S 
phase CDK, the Cdc7-Dbf4 kinase (DDK, Hsk1, Dfp1 in fission yeast), the 
GINS complex, Cut5/Rad4, Drc1/Sld2 and Sld3. Together these proteins 
form the CMG (Cdc45-Mcm2-7-GINS) complex. As verified for Mcm2-7, 
Cdc45 activity is crucial for DNA synthesis initiation and progression of active 
replication forks (Legouras et al., 2006) (Boos et al., 2012). Studies 
undertaken in X. laevis and in S. cerevisiae indicate that Cdc45 also has a 
pivotal role in loading the replication polymerases α and ε onto origins of 
replication (Mimura and Takisawa, 1998) (Aparicio et al., 1999).  
In order to prevent rereplication, origins must fire once and only once per cell 
cycle. Origins switch automatically into their post-replicative state once they 
have fired or have been passively replicated via a passing replication fork. 
They are said to be in an “OFF” state as they can no longer sustain 
replication initiation. This step is known as licensing inhibition. Licensing 
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inhibition can be achieved in many ways. In fission yeast, this process is 
achieved mainly by directing Cdc18 degradation via the SCF, a CDK-Cig2-
dependent reaction (Jallepalli et al., 1997) (Lopez-Girona et al., 1998). 
Degradation of Cdc18 thwarts further loading of Mcm2-7 onto chromatin, 
hence preventing re-firing of post-RCs. In fact degradation of Cdc18 is so 
important to prevent rereplication in S. pombe that overexpressing cdc18+ 
alone induces massive rereplication, a phenotype that is exacerbated by 
Cdt1 co-overexpression (overexpression of Cdt1 alone does not induce 
rereplication) (Lopez-Girona et al., 1998). Mammalian cells presenting Cdt1 
overexpression seem to be particularly prone to rereplication. In mammalian 
systems Cdt1 hyper-accumulation can be achieved either by depleting 
Geminin, an inhibitor of Cdt1 or by ectopic expression of Cdt1. Geminin is not 
conserved in yeast.    
1.4.3 – The role of CDK and DDK activities in replication initiation  
Cdk activity plays a dual role in replication initiation. Together with DDK 
(Cdc7/Dbf4), S-phase CDK initiate origin firing by driving the stable 
association of Cdc45 with Mcm2-7 and the remaining components of the pre-
RC machinery. There is strong biochemical evidence suggesting that the 
various components of the Mcm2-7 are directly phosphorylated by DDK 
during S phase (Weinreich and Stillman, 1999). Interactions between CDK1 
and ORC and Cdc18 have also been reported via co-immunoprecipitation 
studies, suggesting a role for CDK in replication licensing. Furthermore, Sld3, 
which is necessary for the recruitment of Cut5, GINS, Drc1 and Cdc45 is 
phosphorylated in a CDK-dependent manner, in fission yeast (Fukuura et al., 
2011). CDK plays a role of importance in temporally separating the first step 
of replication initiation, origin licensing, from the second step of the same 
process, activation of the helicase activator Cdc45. This temporal separation 
is crucial in preventing re-firing of already fired replication origins, something 
that would either cause lethality or survival of cells presenting an aberrant 
DNA copy number (Tanaka and Araki, 2010).  CDK activity is low at the 
beginning of G1 and it rises throughout G1 until it reaches its first activity 
threshold at the beginning of S phase. This process allows for proper 
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activation of DNA replication origins and subsequent DNA synthesis (Tanaka 
and Araki, 2010).  
 
Figure 1.6 – CDK activity regulates DNA replication initiation 
CDK activity fluctuates throughout the cell cycle with its highest and lowest peaks of 
activity at the beginning and end of M phase, respectively. Formation of preRCs 
takes place during G1 when CDK activity is low. However activation of preRCs 
requires high CDK activity, something that occurs at the beginning of S phase. CDK 
activity is also involved in the inactivation and proteolysis of various factors involved 
in origin firing. Thus, CDK activity plays a dual role in DNA replication initiation (see 
text for details)4. 
If on the one hand CDK activity contributes for the activation of preRCs by 
means of allowing loading of Cdc45, on the other and following activation of 
the pre-RCs, this protein kinase is implicated in inhibiting re-firing of origins 
that have already been activated. This is achieved by downregulating the 
activities of ORC, Cdc6, Cdt1 and Mcm2-7. In budding yeast Orc2 and Orc6 
are know to be directly phosphorylated by Cdk1 (Nguyen et al., 2001) 
(Tanaka, 2010). In addition Cdc6 levels are reduced by Cdk1 via proteolysis 
and inactivation of G1/S transcription (Drury and Diffley, 2009) (Lopez-Girona 
et al., 1998). The second threshold of CDK activity at the end of G2 induces 
mitosis. Following mitosis, mitotic cyclins are degraded via the APC, thus 
bringing the levels of CDK activity down. Given that CDK activity is high 
solely from late M and G1 to beginning of M phase, pre-RCs can only be 
mounted onto chromatin during late M and G1. This prevents pre-RC 
assembly throughout S, G2 and early M phases (Figure 1.6), thus limiting                                                         
4 Adapted from Tanaka et al, 2007. 
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firing of origins to once and only once per cell cycle (Tanaka and Araki, 
2010).        
1.4.4 – DNA rereplication and its biological consequences  
In order to prevent rereplication cells must prevent replication origins from re-
firing. Over-replication within the same cell cycle results in polyploidy, 
aneuploidy, double strand breaks and mitotic catastrophe, all hallmarks of 
cancer development (Hook et al., 2007) (Truong and Wu, 2011). A full 
reduplication of the DNA leads to duplication of the entire genome a 
phenomenon called endoreduplication. Rereplication comes about by re-
firing of individual previously fired ORIs and not because of an additional 
round of replication, a phenomenon known as “the bubble within the bubble”. 
Together these two events are known as over-replication (Legouras et al., 
2006). Rereplication results in activation of the ATM and ATR (Rad3 in 
fission yeast) kinases, markers of DNA structure checkpoint activation (see 
section 1.5) in both mammalian and yeast cells (Takeda and Dutta, 2005) 
(Fersht et al., 2007) (Hook et al., 2007). Elevated levels of Cdc6 and Cdt1 
have been observed in tumours and in various transformed cell lines, 
suggesting that degradation of these licensing factors may act as “an 
important barrier to tumour formation” (Hook et al., 2007). 
There are many mechanisms through which cells can acquire rereplicated 
DNA. In fission yeast overexpression of the licensing factor Cdc18 and 
depletion of the M-phase cyclin Cdc13 are known to induce rereplication, 
preferentially at early firing origins, as determined by FACS analysis (Lopez-
Girona et al., 1998) (Snaith and Forsburg, 1999) (Hook et al., 2007). In 
mammalian cells and in D. melanogaster, overexpression of Cdt1 but not 
Cdc6 (the vertebrate ortholog of S. pombe Cdc18) induces rereplication. This 
can be achieved either by ectopic expression of Cdt1 (in p53-/- cells) or by 
depletion of geminin (in p53+/+ cells), a substrate of the APC that binds and 
prevents Cdt1 from loading Mcm2-7 helicase molecules onto already-fired 
origins of replication during S and G2 phases (Mihaylov et al., 2002) 
(Melixetian et al., 2004). In budding yeast the general idea is that 
rereplication requires the co-overexpression of Cdc6, ORC and Mcm2-7 
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(Nguyen et al., 2001) (Hook et al., 2007). However, novel sensitive methods 
for detection of rereplication such as comparative genomic hybridisation 
analysis (CGH) have shown that deregulation of Cdc6 and ORC is sufficient 
to induce rereplication events that are not detectable via traditional FACS 
analysis methods (Green et al., 2006). In yeast rereplication is avoided 
mainly by CDK-dependent degradation of the licensing factors Cdc18/Cdc6 
and Cdt1, and by CDK-dependent phosphorylation of Mcm2-7 and ORC. In 
mammalian cells, rereplication is kept in check primarily by geminin-mediated 
inhibition and Cdt2-dependent degradation of Cdt1 (Hook et al., 2007). In 
fission yeast Cdt1 is also degraded via the E3 ubiquitin ligase SCF in a Cdt2-
Ddb1-depedent manner (Ralph et al., 2006).   
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1.5 – DNA structure checkpoint responses 
Replicating cells are particular vulnerable to genotoxic stress and DNA 
damage. To safeguard their DNA against these unfavourable insults and 
preserve genomic stability, eukaryotic cells have evolved the DNA structure 
checkpoint signalling pathways (also known as the DNA-damage response, 
DDR) (Warmerdam and Kanaar, 2010). Although this response is not 
essential for regulating the cell cycle as such, its role is of extreme 
importance in ensuring genomic stability (Nyberg et al., 2002). Activation of 
the checkpoint results in alteration of the duration of the different cell cycle 
stages, a process commonly known as cell cycle checkpoint arrest.  
Much of what is known about the DNA structure checkpoints, their control, 
activation, molecular mode of function and downstream targets has been 
acquired from work performed in the yeasts S. pombe and S. cerevisiae 
(Carr, 2002). As observed for all higher eukaryotes, the fission yeast DNA 
structure checkpoints can be divided into the DNA replication checkpoint and 
the DNA damage checkpoint. The fundamental difference between the two 
checkpoints is that the DNA replication checkpoint is essential to prevent 
DNA damage in response to replication stress during S-phase, whereas the 
DNA damage checkpoint is required to detect and resolve DNA damage 
before entry into mitosis. The DNA replication checkpoint prevents the 
accumulation of DNA damage as a result from replication stress by 
stabilizing stalled replication forks, preventing late origins from firing and 
enabling replication to resume once the stress has been resolved. For the 
purposes of this study we will mainly focus our attention on the DNA 
replication and the DNA damage checkpoints (Caspari and Carr, 1999). 
Defects in the various components of the checkpoints are known to be 
involved in the development of genome instability, a hallmark of cancer 
aetiology. Several diseases have been discovered relating mutations in 
checkpoint proteins such as the cancer-prone and hereditary syndrome 
ataxia telangiectasia. Furthermore, given the importance of checkpoint 
activation in the survival of transformed or cancerous cells, checkpoint-
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targeted chemotherapy has been of late, a very attractive therapeutic 
strategy (Chen et al., 2012).  
1.5.1 – The checkpoint signalling pathway 
In order to be able to mount an efficient response against DNA-damage or 
replication stress, cells must be able to, firstly, detect the damage or 
replication block through its sensor molecules, secondly, transform the 
sensed abnormality into a biochemical signal by transducer proteins and 
thirdly, relay the generated signal to downstream effectors capable of 
activating the machinery necessary to delay cell cycle progression and repair 
the insult encountered (Skladanowski et al., 2009). Such a response involves 
a complex signal transduction network, comprising many molecules and a 
series of post-translational modifications, such as phosphorylation and 
ubiquitination. An important part of the checkpoint response involves the 
activation of cell cycle arrest by means of temporarily reducing CDK 
(maintained by CDKIs) and Cdc25 activities (Caspari and Carr, 1999) (Zeng 
and Piwnica-Worms, 1999). Cell cycle arrest ensures that passage of 
damaged DNA to cells at subsequent cell cycle phases is avoided. Please 
note that we will use mainly S. pombe checkpoint-related nomenclature, 
making reference to other organisms whenever appropriate.  
1.5.2  –  Common  elements  of  the  DNA  replication  and  the  DNA 
damage checkpoints 
The discovery of radiation-sensitive mutants led to the identification of 
various checkpoint-related genes in S. pombe, the so-called checkpoint rad 
family of genes (Carr, 2002). Checkpoint proteins fall into one of four major 
categories depending on their role in the checkpoint response and on genetic 
and biochemical findings: sensors (sense directly or indirectly the presence 
of genotoxic stress and initiate the checkpoint signalling), transducers (relay 
and amplify the signal of damage), effectors (lower downstream targets of 
the transducers, usually regulated via phosphorylation) and stabilisers or 
mediators (promote mediation between the transducers and the effectors) 
(Table 1.2) (Nyberg et al., 2002). Whilst the DNA replication checkpoint is 
generally activated by stalled replication forks, the DNA damage checkpoint 
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comes into play when the DNA is affected by a myriad of DNA lesions. These 
include but are not limited to single and double strand breaks (SSB and 
DSB), chemical modifications of the DNA structure caused by alkylation and 
oxidation, mismatched bases, products of ultraviolet (photoadducts and 
crosslinks) and X-ray radiation, amongst others (Boddy and Russell, 2001).  
Table 1-2 Main checkpoint protein orthologs in S. pombe, S. cerevisiae and 
mammals5 
Group Type S. pombe S. cerevisiae Mammals 
Sensors RFC1-like Rad17 Rad24 Rad17 
 
 
PCNA-like 
Rad9 
Rad1 
Hus1 
Ddc1 
Rad17 
Mec3 
Rad9 
Rad1 
Hus1 
 
 
DSB 
recognition/repair 
Rad32 
Rad50 
Mre11 
Rad50 
Xrs2 
Mre11 
Rad50 
Nsb1 
 
 Clamp loader Rfc2-5 Rfc2-5 Rfc2-5 
ATR PI3-kinases 
(PIKK) 
Rad3 
Tel1 
Mec1 
Tel1 ATM Transducers  (also understood as 
sensors) PIKK binding 
partners Rad26 Ddc2/Lcd1 ATRIP 
Effectors Kinase Chk1 Cds1 
Chk1 
Rad53 
Chk1 
Chk2 
Stabilisers/mediators  Mrc1 Crb2/Rhp9 
Mrc1 
Rad9 BRCA1 
 As we shall see in the following sections, there are several checkpoint 
proteins common to both the DNA replication and the DNA damage 
checkpoint signalling pathways. Examples are the ATR-ATRIP (Rad3-
Rad26) complex and the RFC- (Rad17, Rfc2, Rfc2, Rfc4, Rfc5), and the 
PCNA-like (Rad1, Rad9, Hus1) complexes (Furuya and Carr, 2003).  Whilst 
the activation of the DNA replication checkpoint is S-phase specific, the DNA 
damage checkpoint is activated mainly at G2. Initiation of the DNA replication 
and the DNA damage checkpoints leads to activation of the downstream 
effector protein kinases Cds1 and Chk1, respectively (Rhind and Russell, 
2000). It remains largely elusive how, in the light of the existing complex and 
diverse plethora of DNA lesions, a specific lesion activates a particular 
downstream checkpoint response. The current model hypothesises that most                                                         5 Adapted from Nyberg et al, 2002. 
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DNA lesions, capable of changing the conformal structure of the DNA helix, 
are converted into either SSBs or DSBs, two relatively common lesions that 
activate the ATR (Rad3) and the ATM (Tel1) checkpoint pathways (Nyberg et 
al., 2002). Stalled replication forks are known to promote larger than usual 
stretches of ssDNA in Xenopus laevis egg extracts, a signal capable of 
triggering checkpoint responses (Van et al., 2010). It is important to notice 
that these checkpoints are not static. Instead, they are dynamic and highly 
integrated, as they may cross-talk with each other through a series of 
complex signal transduction pathways depending on the type of lesion being 
repaired. However, for reasons of clarity and simplicity they will be presented 
here as separate pathways. 
1.5.3 – DNA replication checkpoint 
1.5.3.1  –  Molecular  Mechanism  of  DNA  replication  checkpoint 
activation 
The DNA replication checkpoint is activated by DNA replication stress 
resulting from stalled replication forks, which can be induced by the depletion 
of deoxyribonucleotide pools (induced for example by drugs such as 
hydroxyurea; HU), DNA replication polymerase inhibition (induced by 
treatment with aphidicolin) and when replication forks collide with unresolved 
lesions that impede normal fork progression along the DNA template (Xu et 
al., 2006).  
In fission yeast, the DNA replication checkpoint cascade depends mainly on 
the Rad3/Cds1 pathway (Figure 1.7; S. cerevisiae Mec1/Rad53 and 
mammalian ATR/Chk1). The replisome continues to unwind DNA 
downstream of a stalled replication fork exposing ssDNA structures (Van et 
al., 2010), resulting in the loading and activation of the transducer and sensor 
phosphatidylinositol 3-kinase-related protein kinase Rad3 in complex with 
Rad26 (the regulatory unit of the complex) to sites of stalled replication forks 
(Bentley et al., 1996) (Chapman et al., 1999). In contrast to their wild type 
counterparts Δrad3 cells are not able to arrest their cell cycle following DNA 
damage or replication stress, something that makes them lose viability in 
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response to genotoxic stress. This loss of viability illustrates the importance 
of the role of Rad3 in the establishment of the DNA replication and DNA 
damage checkpoints (al-Khodairy and Carr, 1992). Rad3 has the ability to 
autophosphorylate in a Rad26-dependent manner (Chapman et al., 1999). 
This autophosphorylation reaction is necessary for further increase of Rad3 
activity and it is important for the activation of the DNA replication and DNA 
damage downstream checkpoint responses (Wolkow and Enoch, 2002).  
In addition to loading of the Rad3-Rad26 complex to sites of halted DNA 
replication, an independent reaction takes place, the loading of the PNCA-
like heterotrimeric Rad9-Rad1-Hus1 clamp (also known as the 9-1-1 clamp) 
via the Rfc2-5-Rad17-like loading complex (Figure 1.7A) (Bermudez et al., 
2003). The 9-1-1 and the Rfc2-5-Rad17 complexes are known to be 
structurally related to the replication processivity factor PCNA and the Rcf1-5 
complexes operating during normal DNA replication, respectively. Binding of 
9-1-1 clamp and Rfc2-5-Rad17-like complexes to sites of stalled replication 
forks is necessary for full activation of Rad3 and Cds1. Apart from its role in 
the activation of the DNA replication and DNA damage checkpoints, the 9-1-
1 complex seems to be important for DNA repair such as in the mechanism 
of mutagenic translesion synthesis and in the repair of DSBs (Parrilla-
Castellar et al., 2004).  
Cds1 is activated via a two-stage mechanism and a complex phosphorylation 
network requiring one basal (T11) and three parallel phosphorylation steps 
mediated by Rad3, Mrc1 and Rad9 (Xu et al., 2006) (Yue et al., 2011). Mrc1 
(mediator of replication checkpoint 1) is a component of the replisome during 
normal replication progression that travels along the replication fork together 
with the replication machinery.  
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Figure 1.7 – The fission yeast DNA replication checkpoint 
The molecular mechanism of the DNA replication checkpoint of S. pombe and 
corresponding responses to replication stress (see text for details). 
In response to replication stress Mrc1 accumulates as a 
hyperphosphorylated molecule. SDS-PAGE experiments in a series of 
mutants have shown that Mrc1 phosphorylation at TQ repeats T645 and 
T653 is Rad3-dependent and that this occurs independently of Cds1 
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presence (Xu et al., 2006). The same study shows that phosphorylation of 
Mrc1 at TQ and SQ clusters is necessary for phosphorylation of Cds1 at 
residue T11 and that Mrc1 binds to inactive Cds1 via its FHA domain, an 
association that seems to facilitate phosphorylation of Cds1 by Rad3. 
Furthermore, in vitro studies have shown that activated Cds1 is capable of 
phosphorylating a kinase-dead form of Cds1, suggesting that full activation of 
Cds1 may include an autophosphorylation step (Boddy et al., 1998). Taken 
together these data suggest that Cds1 is activated via a two-stage 
biochemical mechanism, the priming and the autophosphorylation stages 
(Figure 1.7B). In the first step, the priming stage, Cds1 is recruited to sites of 
halted replication via Mrc1 and then phosphorylated by Rad3. Once bound to 
the chromatin and phosphorylated by Rad3, Cds1 enters the second stage of 
Cds1 activation, the autoactivation stage. At this stage phospho-Cds1 
experiences a Rad3- and Mrc1-independent dimerisation and 
autophosphorylation mechanism, rendering it fully active (Lindsay et al., 
1998) (Xu et al., 2006). A more recent study suggests that activation of Cds1 
is also dependent upon phosphorylation of Rad9 via Rad3 and that Cds1 is 
only fully activated by a basal phosphorylation performed by Rad3 and three 
parallel phosphorylations performed by Mrc1 and Rad9 (Yue et al., 2011). 
 1.5.3.2 –DNA replication checkpoint responses  
The activation of Cds1 promotes many checkpoint-related responses. These 
include cell cycle arrest, stabilisation of DNA replication forks and 
transcriptional induction (Branzei and Foiani, 2009).  
One of the main features of the replication checkpoint is its ability to prevent 
entry into M phase of cells that are unable to fully synthesise their DNA. As 
we saw in section 1.1.2 the onset of M during cell cycle progression is 
inhibited by inactivation of Cdk1 by the CDKIs Wee1 and Mik1. In the fission 
yeast and other eukaryote cells, activation of the DNA replication checkpoint 
also promotes accumulation of Mik1 and its respective orthologs. Increase in 
Mik1 levels results in inhibitory phosphorylation of Cdk1 at Y15 and arrest of 
the cell cycle throughout S phase (Rhind and Russell, 1998) (Rhind and 
Russell, 2001). In addition, inactivation of Cdk1 is maintained via a 
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secondary mechanism that involves phosphorylation and nuclear extrusion of 
inactive Cdc25 molecules (Figure 1.7C) (Zeng and Piwnica-Worms, 1999).  
A second response mediated by activation of Cds1 is the stabilisation of 
paused replication forks. In order to maintain the stability of a paused 
replication fork, association of the replisome with checkpoint proteins is 
essential (Branzei and Foiani, 2009). In mammalian cells RPA (replication 
protein A) is recruited to ssDNA at sites of stalled replication forks in order to 
prevent reannealing of the DNA strand (Sabatinos and Forsburg, 2009). In 
fission yeast, although the ortholog RPA, Ssb3 is not essential for cell 
viability, its deletion results in formation of a high number of Rad22 foci 
(Cavero et al., 2010). Rad22 is a protein that binds DSBs and has a function 
in both the repair of DSBs via homologous recombination and in mating type 
switching, and it is often used as a marker of genomic instability (Ostermann 
et al., 1993). Rad22 foci number will be used in this report as a marker for 
genomic instability. An essential pathway for maintaining stability of stalled 
replication forks corresponds to the Cds1-mediated inactivation of Mus81, a 
Holliday junction resolvase capable of cleaving stalled replication forks (Kai 
et al., 2005). Replication fork halting is not an everlasting event. Once cells 
resolve the block causing DNA replication stalling, they are ready to resume 
replication. 
A third response corresponds to the DNA replication checkpoint 
transcriptional response, which includes the maintenance of the MBF-
dependent G1/S transcriptional programme (de Bruin and Wittenberg, 2009). 
The MBF transcriptional programme includes many genes that promote 
repair of cellular lesions, including stabilization of stalled replication forks and 
induction of DNA repair functions. Persistent expression of MBF-dependent 
genes occurs in cells arrested in S phase with incompletely replicated DNA 
(de Bruin et al., 2008). DNA replication stress-induced activation of MBF-
dependent transcription involves the initial activation of Rad3p, which 
phosphorylates and activates Cds1, which in turn, phosphorylates Nrm1, 
Cdc10, and Ste9, to keep MBF-dependent transcription active. Whereas 
phosphorylation of Nrm1 and/or Cdc10 inhibits the binding of the corepressor 
Nrm1p to MBF at promoters, phosphorylation of Ste9 is thought to inhibit the 
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transcriptional co-activator Rep2 being targeted for destruction by the 
Ste9/APC ubiquitin ligase complex (Dutta et al., 2008) (de Bruin et al., 2008) 
(Chu et al., 2009). Here we show that in response to DNA replication stress, 
and as observed for Nrm1, Yox1 is released from MBF promoters, correlating 
with induction of MBF-dependent transcription. We show that 
phosphorylation of Yox1 at Ser114 and Thr115 by the DNA replication 
checkpoint protein kinase Cds1 is sufficient to keep MBF-dependent 
transcription active. Furthermore we establish that activation of MBF-
dependent transcription is critical for cell survival in response to replicative 
stress. 
1.5.4 – DNA damage checkpoint 
1.5.4.1 – Molecular Mechanism of DNA damage checkpoint activation 
Activation of the DNA damage checkpoint pathway results in phosphorylation 
and activation of the DNA damage effector, serine/threonine protein kinase 
Chk1. Cells deleted for chk1+ are compromised in their ability to respond 
towards DNA damage, hence extremely sensitive to DNA damage inducing 
drugs such as methylmethane sulfonate (MMS) and camptothecin (CPT) 
(Capasso et al., 2002) (Kuntz and O'Connell, 2009). The DNA damage 
checkpoint is highly conserved across eukaryotes, suggesting an early 
development in ancient eukaryote life  (Tel1/Chk1 and Rad3/Chk1 in S. 
pombe, Mec1/Chk1 in S. cerevisiae and the ATM/Chk1 pathway in 
mammals) (Kuntz and O'Connell, 2009).  
As verified for the DNA replication checkpoint, the first step in the activation 
of the DNA damage checkpoint cascade corresponds to the conversion of 
primary DNA lesions into ssDNA. These ssDNA stretches are recognised 
and bound independently by the Rad3/Rad26 complex and by the 9-1-1 
clamp, which again, as established for the DNA replication checkpoint, is 
loaded with the help of the clamp loader Rfc2-5/Rad17 (Parrilla-Castellar et 
al., 2004) (Figure 1.8A). The ATM ortholog, Tel1 plays a role of significance 
in the processing of DSBs. Once these proteins are in place, two BRCT-
domain mediators, Cut5 and Crb2 recruit Chk1 to the checkpoint complex, 
which is rendered active by Crb2-mediated phosphorylation. As discovered 
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for Mrc1, Crb2 contains a pair of conserved TQ/SQ phosphorylation clusters 
that promote the interaction between Crb2 and Chk1 (Saka et al., 1997) (Qu 
et al., 2012). The interaction between Crb2 and Chk1 brings Chk1 into close 
proximity with Rad3, resulting in Rad3-dependent phosphorylation of Chk1 at 
S317, a residue located in the C-terminal regulatory fraction of the protein 
(Lopez-Girona et al., 2001) (Figure 1.8B). Studies undertaken in X. laevis 
suggest that this induces a conformational change of Chk1, which unfolds, 
leaving the kinase domain of the protein free to participate in the 
phosphorylation of downstream targets (Katsuragi and Sagata, 2004). This 
suggests that Chk1 is regulated via an autoinhibition mechanism, whereby its 
conformation state regulates its activity in an “ON or OFF” state. Activated 
Chk1 binds the 14-3-3 proteins Rad24 and Rad25. This interaction is thought 
to be involved in the accumulation of active Chk1 within the nucleus 
(Dunaway et al., 2005). Inactivation of Chk1 is essential for cell recovery and 
re-commencement of the cell cycle once DNA lesions have been repaired. 
This is achieved by dephosphorylation of Chk1 by the phosphatases PP1 
and Dis2 (den Elzen and O'Connell, 2004).   
1.5.4.2 – DNA damage checkpoint responses  
Activation of Chk1 leads to the establishment of many of the DNA damage 
repair pathways, depending on the lesion being repaired: 1) the homologous 
recombination (HR) and the non-homologous end joining repair pathways 
(NHEJ), which repair DSBs; 2) the base excision repair (BER) that excises 
and repairs damaged bases; 3) the nucleotide excision repair (NER), which 
is involved in repairing ssDNA stretches of approximately 24 nucleotides 
long; and 4) the direct reversal DNA repair proteins, alkyltransferases and 
dioxygenases, which repair alkylated and oxidised bases, respectively. 
These pathways are highly integrated (Figure 1.8C) (Helleday et al., 2008).  
As observed for the DNA replication checkpoint, activation of Chk1 results in 
cell cycle arrest by means of Cdk1 and Cdc25 inactivation. Inhibitory 
phosphorylation of Cdk1 at Y15 is achieved by Chk1-dependent 
accumulation of the CDKIs Mik1 and Wee1. Chk1 directly mediates 
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stabilisation of Wee1 and cellular localisation of Cdc25, the latter being 
exported out of the nucleus (Raleigh and O'Connell, 2000).    
 
Figure 1.8 – The fission yeast DNA damage checkpoint 
The molecular mechanism of the DNA damage checkpoint in S. pombe and 
corresponding responses to DNA damage (see text for details). 
 
 
  50 
1.6 – Objectives 
1.6.1 – Objective 1 
Activation of Cds1 leads, amongst other downstream effects to persistent 
expression of MBF-dependent transcripts (de Bruin and Wittenberg, 2009). 
This is achieved, in part, by alleviating Nrm1-mediated MBF transcriptional 
repression (de Bruin et al, 2008). The current model postulates that 
replication stress-induced activation of Rad3 leads to dimerisation and 
activation of the DNA replication checkpoint effector kinase Cds1, which in 
turn phosphorylates and inactivates Cdc10p, Nrm1p, and Ste9p (Dutta et al., 
2008) (de Bruin et al., 2008) (Chu et al., 2009). Given the involvement of 
Yox1 in repressing MBF transcription during normal cell cycle progression we 
ask if there is a role for Yox1 in the DNA replication checkpoint response. In 
this work we show that together with inactivation of Nrm1p, Yox1p 
phosphorylation constitutes a second mechanism through which the DNA 
replication checkpoint acts to maintain MBF transcription in response to DNA 
replication arrest. 
1.6.2 – Objective 2 
G1/S transcription levels are often upregulated in human cancers. In human 
cells the G1/S transcriptional network encompasses hundreds of transcripts. 
In fission yeast over 40 genes have been identified. These include but are 
not limited to the DNA replication initiation factors, responsible for loading of 
the MCM helicase Cdc18 and Cdt1 and the S-phase cyclin Cig2. Cdc18 and 
Cdt1 overexpression has been shown to induce rereplication in S. pombe 
and mammalian cells, respectively. Rereplication is highly detrimental for 
cells. In this report we use the fission yeast model to explore the biological 
effects of keeping G1/S cell-cycle regulated transcription constitutively 
expressed throughout all stages of the cell cycle. We show that cells that are 
unable to turn the G1/S transcriptional programme OFF accumulate genome 
instability. Furthermore, we demonstrate that this is the result of a fine and 
delicate balance between the levels of licensing factors and CDK activity, 
which results in sporadic re-firing of DNA replication origin.  
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2. Methods 
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2.1 – Yeast specific methods 
2.1.1 – Yeast strains and media 
The nrm1Δ and yox1Δ mutants and the yox1-3xHA C-terminal 3xHA-tagged 
strains are as described previously (de Bruin et al., 2008) (Aligianni et al., 
2009). All strains were grown in either YES rich (YE+supplements) or EMM 
(Edinburgh minimal medium) media at 30°C or at 25°C (see Table 2.1 for 
strains list).  
Table 2-1 Strains used in this report 
Strain 
Number Source 
Mating 
Type Strain Notes 
 
RBP4 
 
Russell lab h- 
 
cdc25-22 
 
Temperature sensitive 
 
RBP7 
 
Russel lab h+ 
 
Wt  leu1-32 ura4-D18 
 
 
 
RBP9 
 
de Bruin lab h+ 
 
Δnrm1::hyg 
 
 
 
RBP10 
 
Rhind lab h90 
 
Δres2::ura4 
 
 
 
RBP11 
 
Russell lab h- 
 
Wt  leu1-32 ura4-D18 
 
 
 
RBP31 
 
de Bruin lab h- 
 
Δnrm1::hyg 
 
 
 
RBP35 
 
Boddy lab h- 
 
Δcds1::ura4 
 
 
 
RBP66 
 
de Bruin lab  
 
Δcds1::ura4 Δnrm1::hyg 
 
 
 
RBP127 
 
de Bruin lab h- 
 
Δres1::ura4 
 
 
 
RBP190 
 
Russell lab h- 
 
rad22-YFP::kan 
 
 
 
RBP354 
 
Russell lab h+ 
 
rad22-YFP::kan 
 
 
 
RBP361 
 
de Bruin lab h+ 
 
Δnrm1::hyg rad22-YFP::kan 
 
Cross of RBP9 with RBP190 
 
RBP364 
 
de Bruin lab  
 
Δres1::ura4 rad22-YFP::kan 
 
Cross of RBP127 with RBP354 
 
RBP367 
 
de Bruin lab   
 
Δres2::ura4 rad22-YFP::kan 
 
Cross of RBP10 with RBP190 
 
RBP386 
 
Bähler lab h- 
 
yox1-3HA::kan 
 
 
 
RBP387 
 
Bähler lab h+ 
 
Δyox1::kan 
 
 
 
RBP388 
 
de Bruin lab  
 
nrm1-myc::kan yox1-3HA::kan 
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RBP403 
 
 
de Bruin lab 
 
h+ 
 
 
cdc25-22 
 
 
 
RBP405 
 
de Bruin lab h+ 
 
Δnrm1::hyg Δyox1::kan 
 
Cross of RBP31 with RBP387 
 
RBP406 
 
de Bruin lab  
 
Δyox1::kan Δcds1::ura4 
 
Cross of RBP35 with RBP387 
 
RBP412 
 
de Bruin lab h+ 
 
Δyox1::kan rad22-YFP::kan 
 
Cross of RBP190 with RBP387 
 
RBP425 
 
de Bruin lab  
 
Δcds1::ura4 yox1-3HA::kan 
 
Cross of RBP35 with RBP386 
 
RBP450 
 
de Bruin lab h- 
 
P41nmt1-cig2::kan Nmt1 tagging using the Bahler plasmids  
 
RBP451 
 
de Bruin lab h+ 
 
nrm1Δ::hyg Δyox1::kan rad22-
YFP::kan 
 
Cross of RBP361 with RBP387 
 
RBP452 
 
de Bruin lab h- 
 
yox12A-3HA::kan 
 
Site directed mutagenesis 
 
RBP496 
 
de Bruin lab  
 
Δnrm1::hyg cdc25-22 
 
Cross of RBP4 with RBP9 
 
RBP514 
 
Russel lab h- 
 
Δcig2::ura4 
 
 
 
RBP519 
 
de Bruin lab  
 
Δcig2::ura4 rad22-YFP::kan 
 
Cross of RBP514 with RBP354 
 
RBP520 
 
de bruin lab  
 
Δnrm1::hyg cig2Δ::ura4 
 
Cross of RBP9 with RBP514 
 
RBP529 
 
de Bruin lab  
 
P41nmt1-cig2::kan Δnrm1::hyg 
rad22-YFP::kan 
 
Cross of RBP9 with RBP190 and 
RBP450 
 
RBP533 
 
de Bruin lab  
 
P41nmt1-cig2::kan rad22-YFP::kan 
 
Cross of RBP190 with RBP450 
2.1.2 – Mating/crosses 
Cells were grown from frozen onto selective YES or EMM agar plates and 
allowed to grow for two days at 30°C. Loops of h- and h+ cells were mixed in 
100µl of ddH2O and 10µl plated onto ME plates and left at room temperature 
for 2 or more days. Mating efficiency was checked using a light microscope. 
Cells were picked into 400µl H2O in an Eppendorf tube, 4µl of glusulase (lytic 
enzyme that degrades the cell wall of S. pombe) added and cells incubated 
for at least 4h at 30°C or at room temperature for temperature-sensitive 
mutants. The generated endospores were then washed in water, 
resuspended at 1/100 and 1/1000 dilutions in water and plated onto selective 
plates. Colonies were re-streaked on selective plates and their genotype 
assessed via PCR. HA-tagged strains were identified by western blot 
analysis.  
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2.1.3 –Spot assays 
Cells were grown in YES to saturation in 10ml. Cultures were then 5-fold 
serially diluted and spotted on drug-free and HU- or MMS-containing YES 
plates using a purpose-built, replica-pin apparatus. Plates were incubated for 
at least four days at 30°C and pictures taken using an Epson Expression 
1680 Pro scanner.  
2.1.4 –Transformation –Lithium acetate method 
50ml of S. pombe cultures were grown to OD595=0.8-1. Cell pellets were 
washed with ddH2O and resuspended in 1ml of 0.1M LiAc (pH 7.5), 1MTris-
HCl (pH 8.0) by tube inversion. 100µl of the mixture were aliquoted for each 
transformation, to which 1µg of DNA and 1µg of salmon sperm carrier ssDNA 
were added. The mixture was allowed to sit at room temperature for 5min 
following which, 280µl 40% PEG, 0.1M LiAc (pH7 .5) 10mM Tris-HCl (pH 8.0) 
were added. The mixture was mixed carefully by inverting the tube several 
times and placed in a water bath set at 30°C, without shaking, for 1h. After 
1h 43µl of DMSO were added and the cells heat-shocked at 42°C for no 
more than 5min. Cells were spun down and washed once with ddH2O, 
resuspended in water and spread onto YES/EMM-agar plates. The plates 
were incubated at 30°C for two days and cells replica-plated onto selective 
agar plates. Three to four days later the obtained colonies were re-streaked 
onto fresh selective plates, grown overnight and checked for transformation 
efficiency using either PCR or western blot analysis.     
2.1.5 –Spore microdissection 
Cells were mated as described in section 2.1.2. A loop of crossed cells was 
streak on fresh YES/EMM plates and individual asci picked and placed in line 
with the help of a microdissection microscope (Singer Instruments). Plates 
were then placed at 30°C and following cell wall disruption individual spores 
were picked and placed along a grid. The picked single cells were allowed to 
grow at 30°C or at room temperature (temperature-sensitive mutants), the 
plates photographed using an Epson Expression 1680 Pro scanner and 
individual colonies re-streaked onto selective plates. Genetic background 
was confirmed using PCR analysis.  
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2.2 – Molecular biology 
2.2.1 – PCR – genotyping 
The genotype of transformed or crossed strains was verified by PCR using 
the Bähler method (Bähler et al., 1998). Primers were designed to check 
gene deletion, Pnmt1 N-terminal tagging and C-terminal tagging with for 
example HA. DNA was extracted as described in section 2.3.1 and PCR 
performed using the GoTaq Flexi DNA polymerase (Promega) and a BioRad 
iCycler PCR machine. PCR reactions were run on 0.8 or 1.2% agarose gels 
depending on size of the PCR product and gel photographed using a 
GeneFlash UV transilluminator machine.  
2.2.2 – RT‐PCR 
Total RNA was prepared using the RNeasy Plus Kit (Qiagen) as indicated in 
the manufacturer’s manual. Briefly, cells were resuspended in 400µl and 
disrupted using glass beads and a Fast-prep machine. The obtained samples 
were then centrifuged at 13000 rpm for 1min and the supernatant applied to 
a DNA column. 350µl of 70% ethanol were added to the obtained samples 
and the mixture applied to an RNA column. Columns were washed with RW1 
and RPE buffers and eluted in 100µl RNase-free water. Transcript levels 
were determined by RT qPCR using the iScript One-Step RT-PCR kit with 
SYBR Green Supermix (Bio-Rad). RT-PCR reactions were run on a Chromo-
4 Real-Time PCR Detector (Bio-Rad) and obtained data analysed using MJ 
Opticon Analysis Software 3.0. Finally data was normalised against actin and 
investigated using the C(t) method. 
Table 2-2 Primers used for performing RT-PCR analysis 
 
Name Target Purpose Sequence 
 
Spcdc18 RTRT Fw 
 
Spcdc18 
 
RTRT 
 
GTAGGCATGCAATTGAACTTGCGG 
 
Spcdc18 RTRT Rv 
 
Spcdc18 
 
RTRT 
 
TCATAGCAGATGTCGCTCGGACAA 
 
Spcdc22 RTRT Fw 
 
Spcdc22 
 
RTRT 
 
TGCAACGTGTTGAACGTAACGAGC 
 
Spcdc22 RTRT Rv 
 
Spcdc22 
 
RTRT 
 
AGGTAATGAACGACGACCACGGTT 
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Spact1 RTRT Fw 
 
Spact1 
 
RTRT 
 
CGCCGAACGTGAAATTGTTCGTGA 
 
Spact1 RTRT Rv 
 
Spact1 
 
RTRT 
 
TCAAGGGAGGAAGATTGAGCAGCA 
 
Spcig2 RTRT Fw 
 
Spcig2 
 
RTRT 
 
AGGCATTACTGCTCTTCTCATCGC 
 
Spcig2 RTRT Rv 
 
Spcig2 
 
RTRT 
 
ACGTTCAGCGACACAGACATCTTC 
 
Spste9 RTRT Fw 
 
Spste9 
 
RTRT 
 
TTGTGGTGAGGGATCTCAAGCGAA 
 
Spste9 RTRT Rv 
 
Spste9 
 
RTRT 
 
TTCAACAGAGCCATTGTGTGTGCC 
 
Spsuc22 RTRT Fw 
 
Spsuc22 
 
RTRT 
 
TCCACTGTACTCGCCTATTTCGCT 
 
Spsuc22 RTRT Rv 
 
Spsuc22 
 
RTRT 
 
AACACAACGAGCTTCAGGGATCTG 
 
Sppfh1RTRTFw 
 
Sppfh1 
 
RTRT 
 
CCTCCTTGAACAAATTGGGCGGTT 
 
Sppfh1RTRTRv 
 
Sppfh1 
 
RTRT 
 
TGACGGAAGGTTATCAGACTGGCT 
 
Sppof3RTRTFw 
 
Sppof3 
 
RTRT 
 
GGCCGGTACTAGATTTGTTTCGCA 
 
Sppof3RTRTRv 
 
Sppof3 
 
RTRT 
 
TCTCTCCAGTGTTTGCAGACTTGC 
 
Spams2RTRTFw 
 
Spams2 
 
RTRT 
 
GGCACGTCAAATTCCGACACAGTT 
 
Spams2RTRTRv 
 
Spams2 
 
RTRT 
 
TCCAACCTCGAAGGAGTTCTGCAA 
 
Spcdt2RTRTFw 
 
Spcdt2 
 
RTRT 
 
TGAGACTGGAGCTCTTGAGCTGTT 
 
Spcdt2RTRTRv 
 
Spcdt2 
 
RTRT 
 
TAGCATTGTTGTGAGCAAGCCAGC 
 
Sprhp51RTRTFw 
 
Sprph51 
 
RTRT 
 
TCTGCCATACACTTGCGGTAACCT 
 
Sprhp51RTRTRv 
 
Sprph51 
 
RTRT 
 
GCCAACAAACGAACAGGACGGAAA 
 
SpC644.05cRTRTFW 
 
 
SpC644.05c 
 
 
RTRT 
 
 
GATTTGTACGCGGCTGCTGAATGT 
 
 
SpC644.05cRTRTRV 
 
SpC644.05c 
 
RTRT 
 
GCTAATCCGCTTCTTGGAGCAACA 
 
Spcdt1RTRTFw 
 
Spcdt1 
 
RTRT 
 
ACCGTATGGCCAGAGTCATTTGCT 
 
Spcdt1RTRTRv 
 
Spdct1 
 
RTRT 
 
AATTCAATGGAGCGGGAGAAGGCT 
 
Sppol1RTRTFw 
 
Sppol1 
 
RTRT 
 
ACCGATTGAAGGAACAAACCGTGC 
 
Sppol1RTRTRv 
 
Sppol1 
 
RTRT 
 
AGACTCATACCGCTGAAACGCAGA 
 
Spmr1cRTRTFw 
 
Spmrc 
 
RTRT 
 
TTGCAACGCAACCAACTTGAGGAG 
 
Spmrc1RTRTRv 
 
Spmrc 
 
RTRT 
 
ATCATTTCTAGCGCGTTCAAGCGG 
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Spmik1RTRTFw 
 
Spmik1 
 
RTRT 
 
AAACCACCTCAATCTCCGCTGTCA 
 
Spmik1RTRTRv 
 
Spmik1 
 
RTRT 
 
ACGTTTCATCCGAGCTGTCAGAGT 
 
Spssb1RTRTFw 
 
Spssb1 
 
RTRT 
 
AGGTTCAAGCCGAACATCTGGGAA 
 
Spssb1RTRTRv 
 
Spssb1 
 
RTRT 
 
AGGGCAAGCAGGATATGACACGTT 
 
Sppsm3RTRTFw 
 
Sppms3 
 
RTRT 
 
TGGACATTGATACGCCATCCCAGA 
 
Sppsm3RTRTRv 
 
Sppms3 
 
RTRT 
 
AGTGACTTCTGACCGCCACTCAAT 
 
mug40RTRTFw 
 
Spmug40 
 
RTRT 
 
GCGCGGATTAGTCACAAACTCGAT 
 
mug40RTRTRv 
 
Spmug40 
 
RTRT 
 
TGACGCAACAATTGCAAAGCTGG 
 
rad21RTRTFw 
 
Sprad21 
 
RTRT 
 
AGCTTGGTTCGCCAATGGGATTTC 
 
rad21RTRTRv 
 
Sprad21 
 
RTRT 
 
CCAATCGTTCGCTTCCCAGCAAAT 
2.2.3 –ChIp analysis  
ChIP analysis was carried out as described in Aligianni et al. In summary, 
45ml of exponentially growing cells were treated with formaldehyde (37% v/v) 
for 30min, to 1% final concentration for DNA-protein crosslinking. 
Crosslinking reaction was then stopped by adding glycine (2.5M) to a final 
concentration 125mM. Pelleted cells were washed 3 times with cold TBS, 
resuspended in 500µl lysis buffer complemented with protease and 
phosphatase inhibitors and disrupted as described before. Resulting 
chromatin fractions were subsequently resuspended in fresh lysis buffer, 
sonicated in a Bioruptor (Diagenode) for a total time of 30 min (30 sec ON, 5 
min OFF) and immunoprecipitated with anti-HA antibody (12CA5, Roche) 
overnight, plus 50µl 50% PAS for four more hours. Protein-DNA-bead 
complexes were washed 2 times in 1ml lysis buffer (no inhibitors), 2 times in 
1ml lysis buffer containing NaCl (360mM), 2 times in 1ml wash buffer and 1 
time in 1ml TE buffer, for 15 min in each individual solution. 
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Table 2-3 Primers used for performing ChIP analysis 
Washed complexes were incubated in 100µl of elution buffer for 30 min at 
65°C and resulting supernatants and previously prepared WCEs further 
incubated at 65°C overnight to reverse crosslinking. Finally, samples were 
purified and quantified using the Qiaquick PCR Purification (Qiagen) as 
described in the manufacturer’s protocol. The iQ SYBR Green supermix (Bio-
Rad) kit was used and RT-PCR reactions ran on a Chromo-4 Real-Time 
PCR Detector (Bio-Rad). Data was analysed using MJ Opticon Analysis 
Software 3.0 and values normalised against WCE. 
2.2.4 – Promoter switch of cig2+ to the P41nmt1‐inducible promoter 
Cig2 was placed under the control of the nmt1 promoter at the endogenous 
locus using the Bähler method (Bähler et al., 1998). Succinctly, the plasmid 
pFA6a-KANMx6-P41nmt1 was amplified using TTTTGGTTACAAACAACTA 
GATATATTTCTATACGTTGATAAAAGGGTAATTTATCAATCCATATTTCAT 
GAATTCGAGCTCGTTTAAAC and TGTTTTCATCTTGATAACTATGCTTAT 
TGATTTTAGAACCAACAGGCTTTGAAATTGAATAGAGAGCCATGATTTAA
CAAAGCGACTATA primers; the generated PCR product was then 
transformed into Wt cells using the lithium acetate transformation protocol 
described in section 2.1.4 and positive clones detected by ability to grow in 
kanamycin-YES plates. P41nmt1-tagging of cig2+ was confirmed by PCR for 
insertion of the P41nmt1::kan cassette and by RT-PCR for detecting reduced 
expression levels of cig2+, following addition of thiamine (vitamin B1). 
Name Target Purpose Sequence 
 
Spcdc22 RTChIP Fw 
 
Spcdc22 
 
RT ChIP 
 
ACTTAAAGTTCGGATGACGCGACG 
 
Spcdc22 RTChIP Rv 
 
Spcdc22 
 
RT ChIP 
 
GTTTGTAAGGTGGTAAATACCGGG 
 
Spcdt2 RTChIP Fw 
 
Spcdt2 
 
RT ChIP 
 
CTGGGTAACGTTTGGTGCATGTGA 
 
Spcdt2 RTChIP Rv 
 
Spcdt2 
 
RT ChIP 
 
TGAGGTCGTGTGTTCCAGTT 
 
Spcdc18 RTChIP Fw 
 
Spcdc18 
 
RT ChIP 
 
GGCATTTCATATCTTTGAGGATGAGTCGT 
 
Spcdc18 RTChIP Rv 
 
Spcdc18 
 
RT ChIP 
 
ATGTCGCGTTCAACTCTACGTGTC 
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2.2.5 – Mutagenesis of Yox12A mutant 
DNA corresponding to the Yox12p-3HA stretch (Aligianni et al., 2009) was 
amplified using the GoTaq Flexi DNA polymerase (Promega) and 
CACGGATCTTAAGGGTGACTTC and ATTCGCAACTTCTTTGCTCTTC 
primers. Following PCR purification (Qiagen) the obtained PCR product was 
cloned into the TOPOpCR2.1 plasmid according to the manufacturer’s 
protocol.  
 
Figure 2.1 – Yox12A mutant 
(A) Mutagenesis of the TOPO plasmid and (B) mutagenesis of S. pombe. 
The yox12A-3HA mutants carrying amino acid substitutions S114A and 
T115A were then generated by PCR using the Quick-Change XL site-
directed mutagenesis strategy (Stratagene) and primers 
CTCTCTTTTAAGGAGAAAGGCCGCGTTGACACTCTGCGAAACTTCTAC 
and GTAGAAGTTTCGCAGAGTGTCAACGCGGCCTTTCTCCTTAAAAGAG 
AG. Yox12A-3HA was integrated at the endogenous locus via homologous 
recombination by means of the lithium acetate method and incorporated 
mutations confirmed by DNA sequencing (Figure 2.1). 
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2.3 – Biochemistry 
2.3.1 – DNA extraction 
For each clone 10ml cultures were grown overnight in YES or EMM medium. 
Cells were pelleted and washed in 1ml ddH2O and 200µl TE/SDS buffer 
(10mM TrisCl pH7.5, 1mM EDTA, 3% SDS) were added to the pellet 
followed by a small amount of glass beads. Cells were vortexed for 30sec 
and 500µl of TE added to the mixture. Cells were vortexed again for 30sec, 
followed by addition of 500µl Phenol. Once again cells were vortexed for 
3min and centrifuged for 10min at full speed. 500µl of supernatant (aqueous 
phase) were pipetted into a fresh Eppendorf tube followed by addition of 
350µl isopropanol. The mixture was vortexed for 10min at 13000rpm, the 
supernatant aspirated off and the pellet air-dried for 10min. Finally the pellet, 
containing DNA was dissolved in 30-50µl ddH2O and used for genotyping or 
for cloning of Yox1p-3HA into the TOPO vector.    
2.3.2 – Protein extraction 
Samples were prepared using the TCA protein extraction method. Briefly, cell 
pellets were resuspended in 100µl 20% TCA in a 2ml Eppendorf, glass 
beads added to mixture and cells disrupted on a vortex for 3 minutes. 200µl 
5% TCA were added to the disrupted cells, everything transferred into a fresh 
1.5ml Eppendorf and cells centrifuged for 10 minutes at 3000rpm. Pellets 
were resuspended in 100µl Laemmli sample buffer and 50µl 1M Tris-HCl and 
boiled for 3 minutes in a heat block. Samples were centrifuged for another 10 
minutes at 3000rpm and the supernatants transferred to fresh Eppendorfs.    
2.3.3 – Western Blot analysis 
Samples were prepared as described in section 2.3.2. Samples were ran in 
either 10% precasted Bis-Tris NU-PAGE gels from Invitrogen using MOPS or 
8% and 10% costume-made Tris-Glycine gels using the Laemmli system. 
Proteins were transferred onto PVDF or nitrocellulose membranes by means 
of the semi-dry transfer system, the membranes blocked in 10% milk and 
primary and secondary antibodies diluted in 2% milk as described in table 
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2.4. Membranes were developed using the Luminata Crescendo, Western 
HRP substrates system from Millipore.      
Table 2-4 List of antibodies  
 
2.3.4 – Co‐immunoprecipitation 
For each IP, 50ml of exponentially growing cells were mechanically disrupted 
(FastPrep) in lysis buffer containing protease inhibitors (Complete Mini, 
Roche) and phosphatase inhibitors (Phosphatase Inhibitor Cocktail 1, Sigma-
Aldrich) and glass beads (BioSpec) by 4x30s cycles with 4 minutes cool 
down periods. Subsequently Nrm1p-13myc, Nrm1p-3HA and Yox1p-3HA 
Name Host Purpose Dilution Company and Catalogue number 
 
Anti-HA (12CA5) 
(1ry) 
 
Mouse 
 
Yeast/WB/ChiP 1/1000 
 
Roche, 11583816001 
 
Anti-HA (3F10) 
(1ry) 
 
Rat 
 
Yeast/WB 1/500 
 
Roche, 11867423001 
 
Anti-Myc (1ry) 
 
Mouse 
 
Yeast/WB 1/1000 
 
Santa Cruz Biotechnology, sc-40 
 
Anti-Cig2 (1ry) 
 
Mouse 
 
Yeast/WB 1/2000 
 
Abcam, ab10881 
 
Anti-Tubulin (1ry) 
 
Mouse 
 
Yeast/WB/ 
Immunofluorescence 
1/5000 and 
1/100 
Abcam 
 
Anti-E2F6 (1ry) 
 
Rabbit 
 
Mammalian/WB 1/1000 
 
Santa Cruz Biotechnology, sc-22823 
 
Anti-Cyclin E (1ry) 
 
Mouse Mammalian/WB  1/1000  Santa Cruz Biotechnology, sc-247 
 
Anti-Cyclin A(1ry) 
 
Mouse Mammalian/WB  1/1000 Santa Cruz Biotechnology, sc-53230 
 
Anti-Cdt1 (1ry) 
 
Mouse Mammalian/WB  1/1000  Millipore, #04-1524 
 
Anti-Cdc6 (1ry) 
 
Mouse Mammalian/WB  1/1000 Santa Cruz Biotechnology, sc-9964 
 
Anti-GAPDH (1ry) 
 
Mouse Mammalian/WB  1/1000  GeneTex, GTX627408 
 
Anti-mouse-HRP 
(2ry) 
 
Goat 
 
WB 1/1000 
 
Fisher Scientific, AFPA1-74421 
 
Anti-rat-HRP (2ry) 
 
Goat 
 
WB 1/1000 
 
GE Healthcare Life Sciences, NA935 
 
Anti-rabbit-HRP 
(2ry) 
 
Goat 
 
WB 1/3000 
 
Sigma, A9169 
 
Anti-mouse-FITC 
(2ry) 
 
Goat 
 
Immunofluorescence 1/200 
 
Sigma, F2653 
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were immunoprecipitated with either anti-HA (12CA5, Roche) or anti-myc 
(9E10, Santa Cruz Biotechnology) antibodies, by incubating lysates for 2h at 
4°C with 50µl of 50% protein A Sepharose beads. SDS sample buffer was 
added to protein purified on beads and resolved by 10% SDS-PAGE. Nrm1p-
13myc was detected using the previously described antibody, (12CA5, 
Roche) and Nrm1p-13HA and Yox1p-3HA a high affinity anti-HA (3F10, 
Roche) antibody. 
2.3.5 – Phosphatase treatment 
Lysates deriving from 50ml of exponentially growing cells were enriched for 
Yox1p-3HA as indicated above. Bead bound protein was washed 3x in IP 
buffer containing protease but not phosphatase inhibitors, resuspended in 
900µl of washing buffer, divided into 3 and treated with either IP buffer alone, 
and IP buffer plus active λ-protein-phosphatase (1200 units final 
concentration, Sigma). Samples were then allowed to incubate at room 
temperature for 30 min, disrupted in SDS sample buffer and resolved in 10% 
SDS-PAGE as described previously.   
2.3.6 – Flow cytometry 
Samples were prepared as described in Sabatinos & Forsburg (Sabatinos 
and Forsburg, 2009). Briefly, cells were fixed in 1ml 70% ethanol; 300µl of 
this mixture washed in 3ml 50mM Na citrate, pellets resuspended in 0.5ml 
50mM Na citrate containing 0.1mg/ml RNase A (Sigma) and left at room 
temperature for 2h. A volume of 0.5ml 50mM Na citrate containing 8µg/ml 
propidium iodide (Sigma) was subsequently added to a final concentration of 
4µg/ml and samples sonicated for 30 sec., output control 4 using a Brason 
Sonifier 450 Sonicator prior to flow cytometry analysis. 20,000 single events 
were analysed for FSC, SSC and DNA content using the BD LSR II Flow 
Cytometer and the Flow_Jo v.9.2 Software. 
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2.4 – Cell Biology 
2.4.1 – Rad22 foci quantification 
For each strain, 25ml cultures were grow for a total time of 4.5h in EMM at 
25°C and fixed by resupension in ice-cold 70% ethanol. Fixed cells were 
washed in sterile deonised water, mounted on glass slides using vectashield 
mounting medium, and captured using a Zeiss Axioskop Fluorescence 
Microscope set with a 100x objective, phase contrast 3, attached to a 
Hamamatsu Orca-ER Digital Camera connected to OpenLab software. Cells 
containing Rad22 foci were quantified using Image J Software 1.46j and 
classified according to number, 1 foci or 2 or more foci. 
2.4.2 – Time‐lapse microscopy 
Cells were inoculated in 10 ml YES medium and grown overnight at 30°C. 
The resulting culture was diluted to OD595=0.1 in 10ml of EMM medium and 
grown until OD595=0.8. Following growth at 30°C, 1µl of cells were pipetted 
onto a bed of 2% EMM-rich electrophoresis agarose, prepared as follows: 1) 
200mg of agarose were added to 10ml of EMM medium and heated in a 
microwave oven until the agarose was melted and mixed completely with the 
EMM medium; 2) the resulting mixture was aliquoted into individual 
Eppendorfs and stored at room temperature until needed; 3) immediately 
before mounting the cells, the previously prepared EMM-agarose was melted 
in a water bath at 95°C, 50µl pipetted onto a glass slide and the volume 
compressed into a fine layer (~200µm thick) using another glass slide; 4) 
following solidification, 1µl of freshly resuspended cells were mounted onto 
the EMM-agarose, a coverslip placed on the top of the cells and sealed with 
a 1:1:1 VALAP mixture (vaseline, lanolin and paraffin). The slide was then 
placed in an Axiovert 135 inverted fluorescence microscope. The 
temperature of the microscope chamber was set at 30°C and cells allowed to 
grow for 12h. Images were captured using the Volocity 5.5.1 software for 
26ms, every 3 min with a 20x objective (aperture 0.5), with the focus set for 
autofocus.    
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Figure 2.2 – Time of division quantification 
Freshly grown cells were followed throughout 12 hours and their time of division 
from the first observed division until the second observed division was measured. 
2.4.3 – Cell size quantification 
Using the data obtained from the previously described time-lapse 
experiments, the length of 100 cells was measured from cell-tip to cell-tip, 
immediately before fission using the Volocity v.5.5.1 software. 
2.4.4 – Time of cell division 
Using the data obtained from the time-lapse experiments described in 
section 2.4.2, the time of division was acquired by measuring the time of 100 
fully observed divisions (from the time of a firstly observed fission to the time 
of a subsequent fission) using the Volocity v.5.5.1 software.   
2.4.5 – Cell staining – Hoechst 334 and Calcofluor 
Exponentially growing cells were fixed with 1 ml 70% ice-cold ethanol and 
stored at -20°C until use. Cells were re-hydrated in 1ml PBS, spun down for 
1min at 3000rpm and the supernatant discarded. The pellet was 
resuspended in 100µl 0.02125mg/ml calcofluor and incubated at room 
temperature for 5min. Cells were then washed with 1ml PBS, three times. 
The resulting pellet was resuspended in 5µl 2µg/ml Hoechst (prepared in 
ddH2O) and mounted onto a microscope slide using Vectashield as the 
mounting medium. Images were captured using a Zeiss Axioskop 
Fluorescence Microscope set with a 100x objective, phase contrast 3, 
attached to a Hamamatsu Orca-ER Digital Camera connected to OpenLab 
software. 
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2.4.6 – Immunofluorescence 
Exponentially growing cells were fixed with 1ml ice-cold methanol and 
samples stored at -20°C until needed. Cells were washed three times in 1ml 
PEM (100mM PIPES, 1mM EGTA, Mg2SO4, pH6.9) and digested with 
50units/reaction Zymolyase at 37°C for 20 minutes. Digested cells were then 
washed three times in PEMS (PEM, 1.2M Sorbitol), permeabilised for 30sec. 
in 1ml 1% Triton X-100 in PEMS and washed once in PEM. Cells were then 
blocked by incubating for 50 minutes in PEMBAL (PEM, 0.1M L-lysine, 1% 
BSA, 0.1% Sodium Azide) on a rotary inverter at room temperature and 
resulting pellets resuspended in 30µl 1:100 mouse anti-tubulin (Abcam) 
antibody. Cells were incubated on a rotary inverter for 18 hours, following 
which they were washed three times with 1ml PEM. Finally cells were 
resuspended in 100µl 1:200 anti-mouse-FITC secondary antibody in 
PEMBAL, wrapped in aluminium foil, incubated on a rotary inverter overnight, 
washed three times in PEM, resuspended in 50µl 2µg/m Hoechst and 
mounted onto a microscope slide using Vectashield mounting medium. 
Images were captured using a Zeiss Axioskop Fluorescence Microscope set 
with a 100x objective, phase contrast 3, attached to a Hamamatsu Orca-ER 
Digital Camera connected to OpenLab software. 
  
  66 
 
2.5 – Cell culture 
2.5.1 – Tissue culture – media and growth conditions 
hTERT immortalised retinal pigmentum epithelial (RPE) cells were grown in 
Dulbecco’s Modified Eagle Medium (DMEM)/F12+Glutamax (Gibco,#10565-
018), with 10% fetal calf serum (FCS), supplemented with penicillin and 
streptomycin (Invitrogen) antibiotics at 37°C in T75 flasks (Nunc). Cell 
dissociation was achieved using 0.05% Trypsin-EDTA (1X) (Gibco). 
2.5.2 – SiRNA 
Transfection of cells with siRNA was performed using the Lipofectamine 
2000 (Invitrogen) system according to the manufacturer’s protocol. 
Succinctly, cells were plated in 3cm tissue-culture Petri dishes. 250µl 
Optimem were then mixed with 5µl siRNA (20µM, either siControl, siE2F6a, 
siE2F6b or siE2F7) and in a separate reaction 250µl Optimem mixed with 5µl 
of Lipofectamine 2000. Five minutes after, these two reactions were mixed 
and allowed to form liposomes at room temperature for 20 minutes. Cells 
were then washed two times with PBS and siRNA+Lipofectamin2000 
reactions added to cells together with 1.5ml Optimem. Cells were incubated 
with the referred mixture for up to 6 hours, following which fresh 
DMEM/F12+Glutamax containing antibiotics was added. Cells were collected 
and analysed 48 hours after.   
2.5.3 – Western Blot analysis 
Protein was extracted using RIPA buffer supplemented with protease 
(1/1000) and phosphatase inhibitors (1/1000). Succinctly, Petri dishes were 
washed twice with PBS, 200µl of RIPA buffer added to the Petri dishes, cells 
scraped using a plastic scraper and pipetted into an Eppendorf tube. Tubes 
were centrifuged at 14000rpm for 5min at 4°C and supernatants transferred 
into fresh Eppendorf tubes. Protein concentration was measured using the 
Bradford method as described in the manufacture’s protocol. Samples were 
run using the NUPAGE gels system from Invitrogen as described in section 
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2.3.3. Membranes were blotted with primary and secondary antibodies as 
described in table 2.4.  
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3. The role of Yox1 in the 
DNA replication checkpoint 
response 
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3.1 – Objective 1 – The role of Yox1 in the DNA replication checkpoint 
response 
In response to replication stress the DNA replication checkpoint is required to 
prevent entry into mitosis by blocking Cdc2 activity, stabilize stalled 
replication forks, aid replication fork processivity, and facilitate reinitiation of 
DNA replication once DNA replication stress has been resolved (Murakami et 
al., 2002) (Osborn et al., 2002) (Branzei and Foiani, 2008). A widely used 
method for inducing the DNA replication checkpoint response consists of the 
application of the ribonucleotide reductase inhibitor hydroxyurea (HU), a drug 
known to prevent expansion of the dNTP pool used by cells to replicate their 
DNA (Koç et al., 2004) (Alvino et al., 2007). Several studies have shown that 
HU-dependent activation of Rad3p leads to activation of Cds1p, which in turn 
phosphorylates Cdc10p, Nrm1p, and Ste9p, to keep MBF-dependent G1/S 
transcription on (Dutta et al., 2008) (de Bruin et al., 2008) (Chu et al., 2009). 
Persistent expression of MBF-dependent genes, via inactivation of Nrm1p 
function, is critical for cell survival from DNA replication stress (de Bruin and 
Wittenberg, 2009). Recently Yox1p was identified as an additional MBF co-
repressor to Nrm1p, required to repress MBF transcription outside of G1 
(Aligianni et al., 2009). The level of MBF transcription observed in HU-treated 
cells is comparable to that of both ∆yox1 and ∆nrm1 single mutants (Caetano 
et al., 2011). Based on these observations we hypothesised that just as 
established for Nrm1p (de Bruin et al., 2008), Yox1p could represent an 
additional target of the DNA replication checkpoint to keep MBF transcription 
active.  
3.1.1 – Yox1p and Nrm1p dissociate from MBF promoters in response 
to DNA replication stress. 
In response to HU treatment Nrm1 is unable to bind and repress MBF-
dependent targets. To check if binding of Yox1p to MBF target promoters is 
affected in response to replication stress we carried out Chromatin Immuno-
Precipitation (ChIP) in Yox1p-3HA-tagged cells with or without HU. 
Enrichment of the cdc22+, cdc18+ and cdt2+ promoters by Yox1p-3HA 
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pulldown was measured by means of quantitative PCR (qPCR) analysis. As 
depicted in Figure 3.1 Yox1p is released from cdc22+, cdc18+ and cdt2+ 
promoters following treatment with HU, suggesting that Yox1p is evicted from 
MBF promoters in response to DNA replication stress. Nrm1-3HA-tagged 
cells and actin were used as positive and negative controls, respectively. 
 
Figure 3.1 – Yox1p is unable to bind MBF promoters in response to DNA 
replication stress  
Exponentially growing cultures were allowed to grow for 4h in the absence or 
presence of HU. Promoter fragments obtained from Nrm1p-3HA and Yox1p-3HA 
ChIPs were quantified using qPCR for MBF-dependent genes cdc22+, cdc18+ and 
cdt2+ and for act1+. Bar graphs represent percentage of whole cell extract (WCE) 
signal. Data representative of multiple independent experiments.  
Inactivation and release of Nrm1p from MBF-dependent promoters results in 
increased levels of MBF transcription. In order to see if loss of Yox1p from 
MBF-dependent promoters has the same effect on MBF transcription as 
verified for Nrm1p, we monitored the expression levels of cdc22+, cdc18+ 
and cdt2+ in the untreated and HU-treated Yox1-3HA tagged cells by 
Reverse Transcriptase (RT) qPCR. As expected, the transcription levels of 
the referred transcripts are upregulated following addition of HU (Figure 3.2). 
Treatment with HU resulted in an average 5.2-, 5.9- and 6.1-fold increase in 
the levels of cdc22+, cdc18+ and cdt2+ transcripts in Yox1-3HA cells, 
respectively. 
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Figure 3.2 – Yox1p is unable to repress MBF transcripts in response to DNA 
replication stress  
RT qPCR analysis of RNA levels in untreated and HU-treated Yox1-3HA-tagged 
cells. Fold induction over levels detected in untreated cells is shown. Values are 
normalised against act1+. Error bars represent the SE of three independent 
biological repeats.  
Yox1p-HA was shown to interact with Nrm1p-Myc by co-immunoprecipitation 
(co-IP) experiments of affinity-purified Nrm1p complexes, during normal cell 
cycle progression (Caetano et al., 2011) (Figure 5.1). To investigate the 
interaction between Nrm1p and Yox1p in response to checkpoint activation 
we carried out additional co-IPs and we can conclude that in the presence of 
HU the indicated proteins no longer interact (Figure 3.3). Together these data 
suggest that Nrm1p and Yox1p dissociate not only from MBF promoters but 
also from each other following HU-induced DNA replication stress.  
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Figure 3.3 – Yox1p-3HA dissociates from Nrm1p-13myc following treatment 
with HU  
Western blot analysis of Nrm1p and Yox1p from untreated (Unt) and HU-treated 
(HU) cells. Membranes were blotted for anti-myc (Nrm1p) and anti-HA (Yox1p) as 
described in section 2.3.3. Immunoprecipitation experiments were undertaken as 
indicated in section 2.3.4.  
3.1.2 – Yox1p phosphorylation  in response to HU‐induced replication 
stress is Cds1p‐dependent.  
It has been shown that Nrm1p is phosphorylated in a checkpoint dependent 
manner following HU treatment (de Bruin et al., 2008). Furthermore, 
phosphorylation of the C-terminal region of Cdc10p has also been implicated 
in the mechanism by which the checkpoint activates MBF dependent 
transcription (Dutta et al., 2008). To establish whether Yox1p is 
phosphorylated in response to HU treatment we monitored Yox1p migration 
pattern via SDS-PAGE analysis from untreated and HU-treated Yox1-3HA 
cell lysates. As shown for Nrm1p (de Bruin et al., 2008) treatment with HU 
results in accumulation of a series of higher molecular weight species of 
Yox1p-3HA that migrate slower in the SDS-polyacrylamide matrix compared 
to Yox1p-3HA from untreated cells (Figure 3.4A and 3.4B). To test if the 
slower migrating species of Yox1p-3HA present in HU-treated samples are 
the result of phosphorylation, immunoprecipitated Yox1p-3HA was treated 
with λ-phosphatase. Phosphatase treatment collapses the slower migrating 
species (Figure 3.4A and 3.4B) indicating that Yox1p, like Nrm1p, is 
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phosphorylated in response to checkpoint activation.  Given the involvement 
of Cds1p in the phosphorylation and inactivation of Nrm1p (de Bruin et al., 
2008), we sought to determine whether phosphorylation of Yox1p in 
response to HU is also Cds1-dependent. Analysis of Yox1p-3HA mobility in 
Δcds1 cells after HU treatment reveals that the phospho-shift is impaired in 
the absence of Cds1p, as no species of higher molecular weight were 
detected in the obtained anti-HA blots (Figure 3.4B). Thus, Yox1p 
phosphorylation in response to HU treatment is Cds1-dependent.  
 
Figure 3.4 – Yox1p HU-induced phosphorylation is Cds1p dependent  
(A) Yox1-3HA deriving from untreated and HU-treated cells detected by high-affinity 
anti-HA antibody. Part of Yox1-3HA from HU treated cells was treated with 
phosphatase (PPase) as described in the methods and materials section. (B) 
Yox1p-3HA in HA-enriched lysates from untreated and HU-treated wild type and 
Δcds1 cells. Arrow and letter P indicate, slower migrating, phosphorylated Yox1p-
3HA.  
3.1.3  –  Inactivation  of  Yox1p  is  an  essential  part  of  the  checkpoint 
response. 
Cds1+ null mutant cells are extremely sensitive to the deleterious effects 
caused by HU and MMS (Murakami and Okayama, 1995) (Lindsay et al., 
1998). This is attributable, in part, to their inability to maintain the MBF 
transcriptional programme (de Bruin et al., 2008). Constitutive activation of 
MBF-dependent transcription, as observed in ∆nrm1 cells, suppresses the 
sensitivity of ∆cds1 cells to chronic exposure but does not seem to have a 
role in the acute response to genotoxic stress (Dutta et al., 2008). Based on 
  74 
these observations, we hypothesised that deletion of yox1+, would suppress 
sensitivity of ∆cds1 cells to HU and MMS, by restoring sustained MBF 
transcription. To test this hypothesis we compared the sensitivities of wild 
type, Δcds1, Δnrm1, Δyox1, Δcds1Δnrm1 and Δcds1Δyox1 cells to chronic 
exposure to HU and MMS, through the application of survival assays. The 
obtained results revealed that, like ∆nrm1, deletion of yox1+ suppresses the 
sensitivity of Δcds1 cells to both HU and MMS (Figure 3.5). In this context, 
failure to inactivate Yox1p due to absence of Cds1p is rescued by abrogation 
of Yox1p itself, demonstrating that inactivation of Yox1p is a vital step in the 
checkpoint response.  
 
Figure 3.5 – Inactivation of Yox1p following genotoxic stress is essential for 
cell survival 
Spot assays. Cultures were allowed to grow to stationary phase. Five-fold serially 
dilution of wild type, cds1Δ, Δnrm1, Δyox1, Δcds1Δnrm1 and Δcds1Δyox1 cells were 
then spotted onto YES or YES plus indicated concentrations of HU or MMS. Cells 
were allowed to grow for 3-5 days and pictures taken using a high definition 
scanner. 
3.1.4  –  Phosphorylation  of  Yox1p  at  S114,  T115  sites  plays  an 
important role in checkpoint regulation of MBF transcription. 
Since Nrm1p has been shown to be a direct target of Cds1p in vitro (de Bruin 
et al., 2008) we hypothesized that phosphorylation of Yox1p by Cds1 might 
also be involved in its dissociation from MBF. In an effort to establish the 
requirement of Yox1p phosphorylation for its release from the transcription 
complex, following treatment with HU, we looked for putative Cds1p-
recognition motifs in the Yox1p amino-acid sequence (O'Neill et al., 2002) 
(Seo et al., 2003) (Smolka et al., 2007). We identified one such consensus 
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sequence at amino-acids 111-115 of Yox1p (Figure 3.6A; RRKST). 
Conversion of the Ser114 and Thr115 sites to alanine residues at the 
endogenous locus (yox12A mutant strain, section 2.2.5), results in a dramatic 
effect on the mobility shift of the HA-tagged mutant protein in response to HU 
in vivo (Figure 3.6B).  
 
 
Figure 3.6 – HU challenge induces phosphorylation of Yox1p at its RXXST 
consensus 
(A) Cartoon diagram displaying the molecular arrangement of the homeodomain 
and the putative RXXS/T motif in Yox1p. Not to scale. (B) SDS-PAGE 
electrophoresis of HA-tagged Yox1 in untreated and HU-treated wild type, Δcds1, 
and yox12A cells as described before. (C) RT-qPCR analysis of cdc22+ transcript 
levels corresponding to fold induction over untreated wild type for wild type, Δcds1, 
Δrad3 and yox12A cells. Bars represent the average value, and error bars represent 
their SE, obtained by qPCR of triplicate biological samples. (D) Five-fold serially 
dilution volumes of wild type, yox12A and cds1Δ, cells were spotted onto YES or 
YES plus indicated concentrations of HU or MMS. 
This indicates that the RRKST site is one of the main sites at which Yox1p is 
phosphorylated following activation of the DNA replication checkpoint. 
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Consistent with a possible role in phosphorylation-dependent inactivation of 
Yox1p by Cds1p, we observe significant repression of the MBF target cdc22+ 
in response to HU treatment in the yox12A mutant (Figure 3.6C). The level of 
expression is significantly lower than that observed in wild-type cells but 
somewhat higher than that observed in the ∆cds1 and ∆rad3 checkpoint 
mutants. However, inability to fully induce MBF-dependent transcription in 
response to checkpoint activation in the yox12A mutant does not result in an 
increase in HU sensitivity (Figure 3.4D). We have also monitored the levels 
of Rad22 foci, a marker of genome instability, in yox12A, however no increase 
in genome instability was observed (data not shown).  
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4. G1/S cell‐cycle 
transcription and genome 
stability 
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4.1 – Objective 2 – G1/S‐cell cycle regulated transcription and genome 
stability in S. pombe 
The primary regulation of cell proliferation in mammalian cells is imposed 
during the G1-S transition of the cell cycle. Proliferation requires the 
activation of the G1/S transcriptional programme, which is regulated by the 
MBF transcription factor and the E2F family of transcription factors in fission 
yeast and in mammalian cells, respectively (Reymond et al., 1993) (Cam and 
Dynlacht, 2003). The E2F family of transcription factors is composed of three 
activators (E2F1-3) and five repressors (E2F4-8). In addition it requires three 
co-regulators, the pocket proteins pRb, p107 and p130, to confine 
transcription to G1-S. The high frequency of genetic alterations found in 
tumour cells that affect E2F-dependent transcriptional repression suggests 
that misregulation of this pathway, and hence constitutive G1/S transcription, 
may be necessary for the development of cancer (Chen et al., 2009).  
Whereas derepression of G1/S transcription has clearly been shown to 
contribute to uncontrolled cell division in cancer cells it has also been 
suggested to directly contribute to the accumulation of genome instability 
(Chen et al., 2009). To study the consequences of derepressing G1/S 
transcription on genome stability independent of the loss of control over the 
G1-to-S transition in mammalian cells is hard to do. However, fission yeast 
has an exceedingly short G1 interval in unperturbed cycling cells growing in 
nutrient-rich media. Furthermore G1/S transcription is regulated by a unique 
transcription factor (MBF), which repression can be easily alleviated via 
inactivation of either or both nrm1+ and yox1+ co-repressors. Hence, S. 
pombe represents the perfect model organism to study the effect of 
derepression of G1/S transcription on genome stability. 
In this section we will show that inactivation of the G1/S transcriptional co-
repressors Nrm1 and Yox1 results in de-repression of MBF-dependent 
transcription outside of the G1 phase of the cell cycle. Our work establishes 
that this induces genomic instability probably due to sporadic re-firing of DNA 
replication origins and thereby rereplication. We suggest that this is the result 
of a delicate balance between high levels of the MBF-dependent genes 
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encoding a DNA replication licensing factor (Cdc18) and cyclin (Cig2), hence 
between replication initiation factors and CDK activity. 
4.1.1  –  Deletion  of  nrm1+  and  yox1+  leads  to  constitutive  de‐
repression of MBF transcripts 
ChIP and co-immunoprecipitation studies have shown that is it possible that 
Yox1p binds to MBF promoters through Nrm1p to repress expression of MBF 
transcripts outside of G1/S phases (Figure 5.1) (Caetano et al., 2011) 
(Caetano et al., 2011). To determine the contribution of Nrm1p and Yox1p to 
the repression of MBF-dependent transcription we analysed the expression 
levels of 19 MBF-dependent transcripts in wild type, Δnrm1, Δyox1 and 
Δnrm1Δyox1 cells (Figure 4.1). 
 
Figure 4.1 – Nrm1p and Yox1p require each other to repress MBF transcription 
Relative mRNA levels obtained by RT-qPCR for 19 MBF-dependent transcripts in 
wild type, ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells. Transcript levels are shown as fold-
induction of the lowest transcript levels detected for each gene. Bars represent the 
average value, and error bars represent their SE, obtained by RT-qPCR of triplicate 
biological samples. 
Consistent with data obtained previously from RT-qPCR experiments and 
microarray expression profiling, deletion of either nrm1+ or yox1+ promotes 
an overall upregulation of the MBF transcriptional programme (de Bruin et 
al., 2008) (Aligianni et al., 2009). The fold-induction generated by abrogation 
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of nrm1+ and yox1+ varies widely across the studied transcripts, with a 
maximum of 7.9-fold and 7.5-fold for transcript cdt2+ and a minimum of 1.1-
fold and 1.1-fold for transcript pof3+ in Δnrm1 and Δyox1 cells, respectively.  
The expression signature of the studied transcripts in the single mutants is 
similar, if not identical, to that observed for cells co-deleted for both nrm1+ 
and yox1+, with the exception of transcript cdt2+, which seems to be less 
upregulated in the double mutant than in each individual mutant strain. These 
data indicate that Nrm1p and Yox1p have a mutual dependency for proper 
promoter binding and that this is likely to be the cause for their non-
redundant role in transcriptional repression of MBF. 
4.1.2 – Constitutive expression of G1/S transcription induces abnormal 
progression  through  the  cell  cycle  and  activates  the  DNA  damage 
checkpoint 
In fission yeast cell elongation is normally used as a diagnostic marker for 
cells with cell division defects, cells that do not progress normally through the 
cell cycle, a phenotype known as the cdc- (cell division cycle) phenotype, 
and often associated with genome instability (Nurse et al., 1976). 
Microphotographs of ∆nrm1, ∆yox1, ∆nrm1∆yox1 cells (Figure 4.2A) show 
that constitutive expression of MBF-dependent transcripts generates a cell 
elongation phenotype in these cells. To establish this possibility we 
measured the cell length of 100 cells from cell tip to cell tip of the different 
strains immediately before cell division using time-lapse images (Figure 
4.2B). This revealed that (n=100; mean+/-SE) ∆nrm1 (18.5+/-0.36µm), ∆yox1 
(18.1+/-0.26µm) and ∆nrm1∆yox1 (18.9+/-0.6µm) cells are about 1.31-, 1.28- 
and 1.34-times more elongated on average than their wild type (14.2+/-
0.15µm) counterpart, respectively. This phenotype was particularly 
accentuated in the ∆nrm1∆yox1 double mutants, with a maximum length of 
52.8µm for these cells compared to a maximum length of 17.5µm for wild 
type cells.  
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Figure 4.2 – Constitutive expression of the MBF transcriptional programme 
induces cell cycle delay 
(A) Microphotographs showing wild type, ∆nrm1, ∆yox1, ∆nrm1∆yox1 and 
∆nrm1∆chk1 cells. (B) Whisker plot displaying the maximum, minimum and quartile 
lengths of 100 cells immediately before septation was observed. Statistical 
treatment: unpaired, 2-tail t-student-test, * p<0.05, ** p<0.005, *** p<0.001. (C) Flow 
cytometry DNA profiles of the same cells (see methods and text for further details). 
PE-A=DNA content (D) Frequency histogram displaying the profile of cell division for 
the same strains. Data was binned according to time of division group.  
  82 
Furthermore, FACS analysis of asynchronous populations (Figure 4.2C) 
shows that ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells display a typical cdc- 
phenotype, as their main peaks are wider, lower and more to the right than 
that of wild type cells. Taken together these data suggest that ∆nrm1, ∆yox1 
and ∆nrm1∆yox1 cells may be delayed in S and/or G2 phases, due to 
activation of the DNA replication and/or DNA damage checkpoints.  
In order to assess if the elongated phenotype observed in cells with 
constitutive G1/S expression is the result of DNA damage checkpoint 
activation we have monitored the cell length of 100 cells deleted for both 
nrm1+ and the DNA damage checkpoint effector kinase chk1+. If the 
elongated phenotype was checkpoint-dependent, inactivation of chk1+ 
should suppress cell elongation.  Indeed ∆nrm1∆chk1 cells are on average 
15.14µm long, about 3.3µm less elongated than nrm1+ single mutants and 
only slightly longer than wild type cells. This suggests that ∆nrm1 cells may 
develop DNA damage, which is likely the result of constitutive G1/S 
transcription expression (Figures 4.2A and 4.2B).  To confirm if ∆nrm1, 
∆yox1 and ∆nrm1∆yox1 cells progress abnormally through the cell cycle we 
have examined their cell division profiles using the same time-lapse images 
as before. Whilst the majority of wild type cells take between five to six hours 
to divide, the majority of ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells take either 
longer or shorter periods of time to complete the same task (Figure 4.2D). 
This allows us to conclude that although the average time of division does 
not change significantly between strains, their time distribution does, with 
∆nrm1, ∆yox1 and ∆nrm1∆yox1 cell subpopulations progressing either 
slower or faster through the cell cycle than wild type cells. In addition, and 
not included in the frequency histogram we have observed a much higher 
frequency of cells that were unable to divide in the ∆nrm1∆yox1 strain 
compared to results obtained for wild type and single mutants.  
4.1.3 – MBF transcriptional repression outside of G1/S is essential for 
maintaining genome stability  
Cells abrogated for the MBF repressor Res2p and the co-repressors Nrm1p 
and Yox1p show constitutive overexpression of MBF transcripts, although 
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expression induction is lower in ∆res2 cells  (Figure 4.1) (Zhu et al., 1997) 
(de Bruin et al., 2008) (Aligianni et al., 2009). Although persistent MBF 
transcription is required for survival of cells undergoing replicative stress (e.g. 
HU treatment) as seen in section 3 of this report, results described above 
(4.2.2) prompted us to hypothesise that expression of the MBF transcriptional 
programme outside of G1/S phases may be deleterious to cells undergoing 
normal mitotic division and induce genomic instability.  
 
Figure 4.3 – ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells present genome instability  
(A) Fluorescent microphotographs of Rad22-YFP foci in wild type, ∆res1, ∆res2, 
∆nrm1 ∆yox1 and ∆nrm1∆yox1 cells. (B) Bar graph displaying the quantification of 
Rad22 foci for the strains described in figure 4.3A. Error bars correspond to the SE 
of three independent biological experiments. Statistical treatment: unpaired, 2-tail t-
student-test, * p<0.05, ** p<0.005, *** p<0.001.  
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To further investigate this we monitored formation of Rad22 foci, a marker for 
single stranded DNA, DSBs, collapsed DNA replication forks and persistent 
recombination intermediates in wild type and mutant cells (Kim et al., 2000). 
Abrogation of the MBF repressors Nrm1p, Yox1p and Res2p (Δres2 mutants 
are also more elongated than wild type cells), but not the activator Res1p 
results in accumulation of Rad22 foci (Figure 4.3A). Circa 23.6% and 20% of 
Δnrm1 and Δyox1 cells present formation of single Rad22 foci, respectively, 
compared to only 2.5% of wild type cells (Figure 4.3B). The same is true for 
formation of two or more Rad22 foci. These data further suggest that 
derepression of G1/S transcription causes accumulation of DNA damage. 
4.1.4  –  E‐MAP  analysis  reveals  that  derepression  of MBF‐dependent 
transcription causes replication stress  
Next, to establish the cause and nature of the damage, we carried out 
genome wide epistasis map (E-MAP) analysis of the Δnrm1 deletion mutant 
in collaboration with the Krogan lab (Table 4.1). We anticipated that negative 
interactions identified by this analysis would reveal the proteins required to 
deal with the genotoxic stress caused by nrm1+ inactivation and G1/S 
transcriptional induction. Conversely, positive interactions might reveal 
proteins that cause the genomic instability in ∆nrm1 cells, which we 
anticipated to be direct or indirect targets of MBF. Gene ontology enrichment 
analyses (using cytoscape) revealed that 8% (data not shown) of the genes 
obtained in the E-MAP dataset had functions in DNA repair and/or DNA 
replication checkpoint control (Table 4.1). See Ryan et al (2012) for methods. 
Of the negative interactions many genes encode proteins involved in the 
DNA replication checkpoint control, indicating that the genotoxic stress 
caused by nrm1+ inactivation is likely to result from DNA replication stress. In 
addition a negative interaction was found when inactivating Whi5. Whereas 
Whi5 function in fission yeast is not well established, in budding yeast Whi5 
was identified as an inhibitor of G1/S transcription (de Bruin et al., 2004) 
(Costanzo et al., 2004). This suggests that inactivation of Whi5 might further 
derepress G1/S transcription in ∆nrm1 cells resulting in additional genotoxic 
stress. Based on the negative interaction found in the E-MAP analysis of 
∆nrm1 we conclude that the nature of the genotoxic stress caused by 
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derepression of G1/S transcription is likely to be replication stress, which is 
induced by the upregulation of one or more MBF targets. 
Table 4-1 Δnrm1 epistasis interaction screen  
Interestingly a positive interaction was found with ∆res2. As discussed earlier 
Res2p is thought of as the repressor subunit of MBF. However, whereas 
inactivation of res2+ results in constitutive MBF-dependent transcription, 
transcript levels are around 60% of those observed in ∆nrm1 cells (data not 
shown). Even though Nrm1p is unable to bind MBF in the absence of Res2p 
(de Bruin et al., 2008) this is thought to be the result of the MBF transcription 
Interaction Gene Effect Function 
 
Mms22 
 
-16.4 
 
Repair of resolving DNA replication 
intermediates and prevention of damage 
caused by blocked replication forks 
 
Eme1 
 
-6.2 
 
Holliday junction resolvase subunit 
 
Rad3 
 
-5.9 
 
ATR checkpoint kinase 
 
Mrc1 
 
-5.9 
 
Mediator replication checkpoint 
 
Nse5 
 
-4.9 
 
Replication fork protection 
 
Rad32 
 
-4.6 
 
Nuclease involved in homologous 
recombination 
 
Whi5 
 
-4.2 
 
G1/S transcriptional repressor 
 
Swi3 
 
-4.2 
 
Replication fork protection complex subunit 
 
Rad26 
 
-3.8 
 
Cds1 activation. ATR checkpoint kinase 
regulatory subunit (ATRIP) 
Negative 
 
 
Nse6 
 
-2.0 
 
Replication fork protection 
 
Rad24 
 
2.1 
 
DNA damage checkpoint (14-3-3) 
 
Rad25 
 
2.1 
 
DNA damage checkpoint (14-3-3) Positive 
 
Res2 
 
2.9 
 
G1/S transcription. MBF subunit 
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factor complex being compromised in the absence of res2+. Importantly 
inactivation of both Res2p and Nrm1p results in transcript levels similar to 
that observed in ∆res2 (data not shown). The positive interaction observed 
therefore suggests that the level of induction of MBF targets is a direct 
measurement of the genotoxic stress induced by the derepression. 
Disappointingly, none of the known MBF targets tested in the E-MAP 
analysis were found to have a positive interaction with nrm1+ inactivation. 
Based on those results we were unable to predict which MBF targets cause 
the replication stress. However, not all MBF targets were included in the E-
MAP analysis. Most notably cig2+ and the essential genes cdc18+ and cdt1+ 
were missing. Interestingly all three are involved in regulating DNA 
replication, and our E-MAP analysis suggests that derepression of MBF 
targets causes replication stress. 
4.1.5  –  High  levels  of  DNA  replication  licensing  factors  may  cause 
genomic instability  
Based on the previous results we hypothesise that accumulation of the 
licensing factors Cdc18p and Cdt1p (Figure 4.1) may be the cause of why 
these cells present more genome instability than their wild type counterparts, 
as their overexpression is known to generate rereplication and 
endoreduplication. We also predict, based on the DNA profiles of these cells 
(Figure 4.2) that de-repression of G1/S transcription induces sporadic 
rereplication and not full endoreduplication. Surprisingly, given the redundant 
role of Nrm1p and Yox1p in repressing MBF transcription, a much higher 
frequency of cells containing Rad22 foci was observed for the nrm1+ and 
yox1+ double mutant than for each of the individual mutant strains. Analysis 
of the G1/S transcriptional programme of ∆nrm1∆yox1 cells (Figure 4.1) 
shows that this strain presents lower levels of cdt2+ than ∆nrm1 or ∆yox1 
single mutant strains. As observed for mammalian cells Cdt2p is involved in 
the degradation of Cdt1p in fission yeast. These results indicate that 
∆nrm1∆yox1 may accumulate higher levels of Cdt1p than ∆nrm1 and ∆yox1 
single mutant cells and that, given that cdc18+ is also upregulated in these 
cells, sporadic rereplication may be enhanced. Hence the additional genomic 
instability observed in the double mutant strains. It is reasonable to suggest 
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that Nrm1p and Yox1p may regulate the expression of cdt2+ differently 
compared to other G1/S genes.  
4.1.6 – Derepression of G1/S transcription causes aberrant DNA  
 
Figure 4.4 – ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells show morphologic defects 
(A) Quantification of wild type, ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells presenting 
aberrant phenotype. Results are represented as percentage of whole cell 
population. Statistical treatment: unpaired, 2-tail t-test, * p<0.05, ** p<0.005, *** 
p<0.001. (B) Photomicrographs displaying examples of the aberrant phenotypes 
observed. (C) Quantification of aberrant cells per morphological defect group. Note 
the higher incidence of scattered DNA and chitin accumulation compared to the 
other aberrant phenotypes. Results are presented as percentage of whole cell 
population. Error bars correspond to the SD of three independent biological 
experiments looking at approximately 500 cells per experiment.  
Another indicator of genomic instability is the detection of aberrant DNA. 
Expression of G1/S transcription outside of G1/S phases causes a 
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statistically significant increase in cells presenting aberrant cell morphology 
compared to wild type cells (Figures 4.4A, B and C). We have stained all 
strains for their nucleus (Hoechst 33342) and septum (calcofluor) and 
measured the number of cells presenting aberrant morphology. In average 
(n>250; mean+/-SD), about 0.7+/-0.38%, 1.7+/-0.4% and 4.4+/-0.8% of 
∆nrm1, ∆yox1 and ∆nrm1∆yox1 cells present aberrant phenotypes, 
respectively, compared to only 0.07+/-0.06% of wild type cells.  
Several morphological defects have been detected: cells with more than 2 
nuclei and 1 septum, trinucleated cells presenting more than 1 septum, cells 
presenting chromosome misegregation (scattered DNA), cells with cut 
phenotype, cells with accumulated chitin, cells donated with filamentous 
growth, amongst others (Figure 4.4C). We attribute the pleiotropic nature of 
the aberrant morphologies observed to the fact that these are the 
consequence of the replication stress caused by the induction of G1/S 
transcripts in these mutants (Figure 4.1). We hypothesise that Cdc18p and 
Cdt1p may play a predominant role in indirectly causing the genomic 
instability detected in the studied mutants. 
4.1.7 – Genetic interaction of Nrm1p and Yox1p with Cig2p 
A number of observations have prompted us to analyse the interaction 
between Δnrm1 and Δyox1 mutants with Δcig2 cells. Firstly cig2+ was the 
only non-essential MBF target that was not represented in our E-MAP study. 
Secondly, Cig2p is involved in the degradation of Cdc18p through the 
ubiquitin ligase SCF at the beginning of S-phase (Lopez-Girona et al., 1998) 
(Kominami and Toda, 1997). Since we hypothesise that overexpression of 
Cdc18p in ∆nrm1 cells might cause replication stress, Cig2p might be 
required for viability of ∆nrm1 cells. Thirdly, Cig2p/Cdc2p has been reported 
to phosphorylate MBF on its DNA-binding subunit Res1p at residue S130 
(Ayté et al., 2001). Inactivation of cig2+, or loss of S130 phosphorylation has 
been suggested to induce prolonged activation of G1/S transcription (Ayté et 
al., 2001). If Cig2p and Nrm1p or Yox1p have independent effects on MBF-
regulated transcription, then the ∆nrm1∆cig2 and ∆yox1∆cig2 double mutants 
should be additive in terms of their effect on MBF transcription and, perhaps, 
in terms of cellular phenotype. In order to test this hypothesis we have 
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crossed ∆nrm1 and ∆yox1 cells with ∆cig2 cells. As predicted, crosses of 
∆nrm1 and ∆yox1 with ∆cig2 give rise to lethal or highly compromised 
haploid segregants (Figure 4.5A).  
 
Figure 4.5 – Genetic interaction of ∆nrm1 and ∆yox1 mutants with ∆cig2 cells 
(A) Haploid ∆nrm1 and ∆yox1 mutants carrying an integrated Rad22-YFP construct 
were crossed with a ∆cig2 mutant and haploid meiotic segregants dissected as 
described in the methods and materials section. Segregants were analysed for 
presence of wild type, each of the parental disruption and the double mutant. No 
healthy double mutants were observed (B) DNA FACS profile of the same cells. 
DNA was stained with propidium iodine (C) Photomicrographs displaying the 
aberrant morphology of the ∆nrm1∆cig2 double mutant. Cells were stained for 
nucleus and septum using the dyes Hoechst 33242 and calcofluor, respectively.  
Examination of ∆nrm1∆cig2-germinated spores reveals a dramatic elongated 
shape, characteristic of cell cycle arrest, and striking morphological defects 
widely spread across the cell population (Figure 4.5C). Examples include but 
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are not limited to missegregated and broken chromosomes, multiseptated 
cells and filamentous growth. Furthermore, these cells present enhanced 
DNA damage as measured by formation of Rad22 foci compared to ∆nrm1 
single mutants (Figure 4.6A and B). Furthermore, ∆nrm1∆cig2 cells present a 
statistically significant increase in the formation of two or more Rad22 foci 
compared to ∆nrm1 cells (Figure 4.6A and B).  
 
Figure 4.6 – Genome instability is enhanced in ∆nrm1∆cig2 mutants compared to 
∆nrm1 and ∆cig2 single mutants 
(A) Microphotographs displaying formation of Rad22 foci in ∆cig2 and ∆nrm1∆cig2 
cells. Cells were grown for 4h in EMM medium as described in the methods and 
materials section. (B) Quantification of Rad22 foci in ∆cig2 and ∆nrm1∆cig2 
mutants. Error bars correspond to the SE of three independent biological 
experiments. Statistical treatment: unpaired, 2-tail t-test, * p<0.05, ** p<0.005, *** 
p<0.001.  
We have considered two hypotheses to explain the synthetic lethality or 
aberrant morphology observed between ∆nrm1 and ∆cig2, and ∆yox1 and 
∆cig2 interactions: 1) deletion of cig2+ in a ∆nrm1 and a ∆yox1 background 
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may induce further rereplication due to accumulation of Cdc18p protein 
levels (Lopez-Girona et al., 1998); 2) alternatively, given the role of Cig2p in 
negatively regulating the MBF activator Res1p, deletion of cig2+ may lead to 
enhanced levels of MBF transcription and hence more genome instability 
(Ayté et al., 2001). Additionally both issues might contribute to the negative 
synergy. 
To test the first hypothesis we analysed the DNA profile of ∆nrm1∆cig2 
double mutant cells for increase in DNA content compared to single mutants 
alone via FACS analysis. As depicted in Figure 4.5B, the DNA content of 
these cells is much higher than that of wild type cells and ∆nrm1 and ∆cig2 
single mutant cells, indicating that these cells present enhanced 
rereplication. If the second hypothesis is right then we expect ∆cig2 single 
mutant cells to contribute to some extent to the presence of genome 
instability, as measured by means of formation of Rad22 foci and as 
observed for the repressor Res2p and the co-repressors Nrm1p and Yox1p. 
As shown in figures 4.6B this is not the case. cig2+ mutant cells look rather 
normal compared to ∆nrm1 and ∆nrm1∆cig2 mutants (Figure 4.5C and 
Figure 4.6B). Furthermore, only circa 2.7% of ∆cig2 cells present formation of 
single Rad22 foci, a value that is highly comparable to that of wild type cells 
(2.5%). These results prompted us to hypothesise that disruption of cig2+ is 
not sufficient to fully alleviate MBF transcriptional repression. To test this 
hypothesis we measured the expression levels of cdc18+ and cdt1+ 
transcripts in wild type, ∆nrm1, ∆cig2 and ∆nrm1∆cig2 asynchronous 
populations (Figure 4.7). In contrast to previous findings (Ayté et al., 2001), 
we have not observed an increase in the levels of MBF transcription in ∆cig2 
mutant cells compared to wild type counterparts (Figure 4.7). Furthermore, 
deletion of cig2+ in a ∆nrm1 background does not seem to further enhance 
MBF transcription, as levels of cdc18+ and cdt1+ transcripts in ∆nrm1∆cig2 
double mutants are similar to those observed for ∆nrm1 cells (Figure 4.7). 
Altogether these data suggest that the basis of the synthetic lethality and 
morphological defects observed for ∆nrm1∆cig2 and ∆yox1∆cig2 mutants is 
the result of enhanced accumulation of Cdc18p protein levels due to 
unavailability of Cig2p to target Cdc18p for proteolysis. 
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Figure 4.7 – Deletion of cig2+ does not promote alleviation of MBF transcriptional 
repression  
RT-PCR relative levels for Cdc18+ and Cdt1+ transcripts in wild type, ∆nrm1, ∆cig2 
and ∆nrm1∆cig2 cells. Cells were grown for 4h in EMM medium. Results are 
represented as relative mRNA levels. Error bars correspond to the SE of three 
independent biological experiments. 
4.1.8 – Cdc18p and Cig2p proteins accumulate in ∆nrm1 cells 
Abrogation of nrm1+ leads to constitutive upregulation of G1/S transcripts, 
and the accumulation of genomic instability (Figure 4.1). Our results, 
discussed above, suggest that the genomic instability is caused by 
replication stress as a result of overexpression of the licensing factor Cdc18. 
Furthermore the extent of the replication stress is likely limited by the 
overexpression of Cig2p. In order to check if Cdc18p and Cig2p accumulate 
at the protein level in cells that are unable to repress MBF-dependent 
transcription, we have measured the protein levels of these genes in cell 
extracts deriving from wild type and Δnrm1 cells. In agreement with the 
transcriptional data depicted in Figure 4.1, Cdc18p and Cig2p protein hyper-
accumulate in Δnrm1 cells (Figure 4.8). This reveals that overexpression of 
MBF transcripts at the mRNA level upon abrogation of nrm1+ correlates with 
the protein level, and that proteins encoded by MBF targets hyper-
accumulate in the absence of Nrm1p-dependent repression (see also section 
6.2). The same is expected to be true for abrogation of yox1+. 
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Figure 4.8 – Cdc18p and cig2p protein levels in Δnrm1 cells. 
Western blot analysis of the protein levels of Cdc18p and Cig2 in Wt and Δnrm1 
cells. Cdc18p was tagged with HA and detected with anti-HA antibodies. Cig2p was 
detected with a commercially available anti-Cig2 antibody as described in section 
2.3.3.  
4.1.9 – Genomic instability in ∆nrm1 cells is dosage dependent on Cig2 
levels 
Constitutive derepression of MBF by means of abrogation of the MBF co-
repressors nrm1+ and yox1+ results in elevated transcript levels of both DNA 
replication initiation factors cdc18+ and cdt1+ and the S-phase cyclin cig2+ 
(Figure 4.1 and 4.8). ∆nrm1∆cig2 double mutants present more genome 
instability than ∆nrm1 single mutants, suggesting that a delicate balance of 
high levels of Cig2p and Cdc18p exists in ∆nrm1 cells and that 
hyperaccumulation of Cdc18p may be counteracted by hyperaccumulation of 
Cig2p, which targets Cdc18p for proteasome-dependent protein degradation.  
In order to determine the role of Cig2p in counteracting the effects of cdc18+ 
overexpression observed in our ∆nrm1 mutant, we have established a strain 
carrying an inducible cig2+ construct. To construct this strain we have 
replaced the wild type promoter of cig2+ by an inducible promoter, the 
P41nmt1 promoter, at the endogenous locus and crossed the generated 
strain with ∆nrm1 cells (Figure 4.9B). The nmt1 (for no message in thiamine 
1) promoter is regulated by thiamine, also known as vitamin B1. Addition of 
thiamine to exponentially growing cells results in full repression of transcripts 
regulated by the nmt1 promoter within 3h (Maundrell, 1990), making it a very 
powerful tool in yeast genetics.  
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Figure 4.9 –The interaction of Δnrm1 with P41nmt1cig2 - experimental design 
(A) Cells were allowed to grow in thiamine-free EMM medium for 4h before point 0h 
was taken. Thiamine was added, to repress transcription from the P41nmt1 
promoter, at a final concentration of 15µM and cultures allowed to grow for 24h. 
Cultures were diluted to OD595=0.025 at 12h to ensure that cultures were at 
exponential growth throughout the entirety of the experiment. (B) Cartoon diagram 
displaying the expected levels of cig2+ and MBF transcripts in untreated and 
thiamine-treated P41nmt1cig2 and P41nmt1cig2 ∆nrm1 cells.  
 
Figure 4.10 – Cig2p levels in the P41nmt1cig2 inducible system 
(A) Wild type, ∆nrm1, P41nmt1cig2 and P41nmt1cig2 ∆nrm1 cells were allowed to 
grow for 24h in the presence of thiamine and the levels of Cig2p measured by 
means of SDS-PAGE analysis at 0h, 13h and 24h time points. Tubulin is shown as 
the loading control. 
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To test if our inducible system was working we have monitored the protein 
levels of Cig2p in wild type, ∆nrm1, P41nmt1cig2 and P41nmt1cig2 ∆nrm1 
cells by western blot analysis, according to the experimental conditions 
described in Figure 4.9A. As expected the levels of Cig2p were 
downregulated, 13h and 24h after addition of thiamine, both in P41nmt1cig2 
and P41nmt1cig2 ∆nrm1 cells but not in wild type and ∆nrm1 cells (Figure 
4.10). Furthermore, Cig2p levels are slightly increased in P41nmt1 cells 
compared to ∆nrm1 mutants.  
 
Figure 4.11 – cig2+, cdc18+ and cdt1+ mRNA levels in the P41nmt1cig2 inducible 
system 
Experimental conditions were as explained in Figure 4.9. Bar graphs representing 
the relative mRNA levels for transcripts cig2+ (A), cdc18+ (B) and cdt1+ (C) of wild 
type, Δnrm1, P41nmt1cig2 and P41nmt1cig2 Δnrm1 cells 0h and 24h after addition 
of thiamine. Transcript levels are shown as fold-induction of the lowest transcript 
measured. Bars represent the average value, and error bars represent their SE, 
obtained by RT-qPCR of triplicate biological samples.  
Next we examined the RNA levels of cdc18+, cdt1+ and cig2+ in the same 
cells. These studies revealed that cdc18+ and cdt1+ transcripts were 
unaffected by the repression or induction of P41nmt1cig2 (Figure 4.11B and 
C). Repression of cig2+ in a ∆nrm1 background (P41nmt1cig2 ∆nrm1 cells) 
does not result in further increase in the levels of cdc18+, similar to what we 
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observed in ∆cig2∆nrm1 double mutants (Figure 4.11B). Overall, addition of 
thiamine represses cig2+ levels in both P41nmt1cig2 and P41nmt1cig2 
∆nrm1 cells, proving that the system is working as expected (Figure 4.11A).  
 
Figure 4.12 – Addition of thiamine induces aberrant phenotypes in P41nmt1cig2 
Δnrm1 cells 
Microphotographs of wild type, Δnrm1, P41nmt1cig2 and P41nmt1cig2 Δnrm1 cells 
stained for their nucleus (Hoechst 33242) and septum (Calcofluor) before and after 
treatment with thiamine. White arrows indicate cells with aberrant phenotypes. 
Examples include missegregated chromosomes, multinucleated cells and 
filamentous growth.  
In order to measure the effects of downregulating cig2+ on the cell 
morphology of P41nmt1cig2 ∆nrm1 mutants we treated cells with thiamine 
and co-stained cells for their septum and nucleus using calcofluor and 
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Hoechst 33242, respectively. Observation of thiamine-treated P41nmt1cig2 
∆nrm1 cells under the microscope revealed a phenotype that highly 
resembles that of ∆nrm1∆cig2 cells, suggesting that high levels of cig2+ are 
essential for the survival of cells deleted for nrm1+. These cells are wider and 
highly elongated compared to wild type, ∆nrm1 and P41nmt1cig2 cells. 
Furthermore, they also present filamentous growth and missegregated 
chromosomes, phenotypes that are symptomatic of genome instability 
(Figure 4.12). In addition we have immunostained thiamine-treated P41nmt1-
cig2 ∆nrm1 cells for their microtubules using anti-tubulin antibodies (Figure 
4.13). We have noticed that the microtubules of these cells are highly 
elongated and that chromatin is stretched along the mitotic spindle in the 
majority of these cells, suggesting that cytokinesis may also be 
compromised. 
 
Figure 4.13 – Chromatin stretches across the mitotic spindle in P41nmt1cig2 Δnrm1 
cells following treatment with thiamine.  
Microphotographs of thiamine-treated P41nmt1cig2 ∆nrm1 cells stained with 
Hoechst for nucleus and immunostained with anti-tubulin antibodies for microtubules 
as described in sections 2.2.4.5 and 2.4.6, respectively. Note the highly elongated 
phenotype of the microtubules and the chromatin stretched along the microtubule 
spindle.   
To determine if repressing cig2+ induces further genomic instability in our 
∆nrm1 single mutants as verified for ∆nrm1∆cig2 cells we have treated 
P41nmt1cig2 ∆nrm1 cells with thiamine as described above and measured 
the levels of Rad22 foci formation in these cells. As expected addition of 
thiamine to P41nmt1cig2 ∆nrm1 cells induces an increase in genome 
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instability compared to ∆nrm1 and control P41nmt1cig2 cells (Figure 4.14B). 
Although these cells continue to divide, their cell cycle is highly disturbed, as 
they progress extremely slowly through the cell cycle. Conversely, cig2+ 
overexpression in the P41nmt1cig2 ∆nrm1 cells, observed before thiamine 
addition, partially rescues the genomic instability phenotype observed in 
∆nrm1 cells, as these present slight less formation of Rad22 foci than ∆nrm1 
cells (Figure 4.14). Although this event is not statistically significant this 
suggests that further overexpression of Cig2p in these cells may more 
effectively counteract the rereplication induced by overexpression of Cdc18p. 
Further experiments would need to be performed to confirm this hypothesis. 
 
 
Figure 4.14 – cig2+ repression in P41nmt1cig2 Δnrm1 cells results in increased 
genome instability 
(A) Microphotographs of wild type, nrm1, P41nmt1cig2 and P41nmt1cig2 ∆nrm1 
cells expressing Rad22-YFP, 0h and 24h after treatment with thiamine. (B) 
Quantification of A. Bars represent the average value, and error bars represent their 
SE, obtained by RT-qPCR of triplicate biological samples. 
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If the derepression of MBF transcription observed in ∆nrm1 cells results in a 
delicate balance between high levels of Cdc18p, that induces re-firing of 
replication origins, and Cig2p counteracts this by targeting Cdc18p for 
destruction, downregulation of Cig2p in ∆nrm1 cells should induce high levels 
of rereplication. To test this we analysed the DNA profile of P41nmt1cig2 
∆nrm1 cells following addition of thiamine to repress cig2+ levels. True to our 
assumption downregulation of Cig2 in ∆nrm1 cells causes the accumulation 
of >4C DNA content (Figure 4.15A). In addition the analysis of the FCS vs. 
PE dotplot of these cells reveals the existence of a cohort of cells (6.11% of 
the cells) with reduced DNA content. We assume that these correspond to 
cells that underwent chromosomal mis-segregation and display a so-called 
cut phenotype (Figure 4.15B).  
 
Figure 4.15 – cig2+ repression in P41nmt1cig2 Δnrm1 cells results in enhanced 
rereplication and cells presenting cut phenotype 
(A) DNA FACS profile of wild type, ∆nrm1, P41nmt1cig2 and P41nmt1cig2 ∆nrm1 
before and after addition of thiamine. Cells were treated with thiamine for 24h. (B) 
FSC-A vs PE-A dotplot of the same cells. Cells were gated for cut-phenotype cells.  
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Cells depleted for Cdc13 have been shown to re-replicate their DNA without 
intervening mitoses (Lopez-Girona et al., 1998). One could argue that lower 
levels of Cdc13p could be the cause of why ∆nrm1 and thiamine-treated 
P41nmt1cig2 ∆nrm1 cells undergo rereplication. In order to check if ∆nrm1 
and thiamine-treated P41nmt1cig2 ∆nrm1 cells present normal levels of 
Cdc13p, we have monitored the protein levels of Cdc13p in these strains by 
western blot analysis. We observed that the levels of Cdc13p are not 
downregulated in either ∆nrm1 or thiamine-treated P41nmt1cig2 ∆nrm1 cells 
(Figure 4.16). Altogether these results indicate that the rereplication 
phenotype observed in these mutants is directly related to downregulation of 
Cig2p levels and not with indirect downregulation of Cdc13p. 
 
Figure 4.16 – Rereplication observed in Δnrm1 and thiamine-treated P41nmt1cig2 
Δnrm1 cells is not due to decrease in Cdc13 levels  
Cells were grown in the absence and presence of thiamine, protein extracted and 
samples analysed using SDS-PAGE analysis. Membranes were probed for Cdc13p 
using an anti-Cdc13 antibody kindly provided by Hiro Yamano. Tubulin is used as 
loading control. 
4.1.10 – Downregulation of E2F6  induces an  increase  in  the  levels of 
Cdt1 and Cyclin A in immortalised RPE human cells 
Our work in fission yeast has shown that derepression of G1/S transcription 
leads to genomic instability via the upregulation of licensing factors resulting 
in the induction of rereplication. Next we sought to establish if this is also true 
for mammalian cells. G1/S cell cycle dependent transcription in mammalian 
cells is regulated by the E2F family of transcription factors (Zhu et al., 2004). 
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E2F6 and E2F7 are repressors of the E2F transcriptional programme. Much 
like Nrm1 and Yox1 in fission yeast they are G1/S targets themselves and 
therefore involved in a negative feedback loop to turn off transcription during 
the G1-to-S transition (Di Stefano et al., 2003) (Lyons et al., 2006). Amongst 
a large number of genes the E2F transcription factors are involved in the 
controlling the expression of the licensing factors Cdc6 and Cdt1, and Cyclin 
E and Cyclin A (Schulze et al., 1995) (Yoshida and Inoue, 2004) homologs of 
the fission yeast Cdc18 and Cdt1, and Cig1 and Cig2, respectively. In 
mammalian cells overexpression of CDT1 is known to induce rereplication, 
whereas as discussed above in fission yeast overexpression of Cdc18p 
(CDC6 homolog) has the most pronounced effect. Cyclin A is involved in the 
degradation of CDT1, much like Cig2p is involved in targeting Cdc18p in 
fission yeast (Sugimoto et al., 2004). 
 
Figure 4.17 – Protein levels of several E2F-regulated genes in siE2F6- and siE2F7-
treated cells  
RPE cells were left untreated or treated with 2 types of siE2F6 and one type of 
siE2F7 and the proteins levels of E2F6, Cyclin E, Cyclin A, CDT1 and CDC6 
detected by western blot analysis as explained in the methods section. GAPDH was 
used as loading control.   
Based on this we speculated that, as shown for S. pombe, depletion of cyclin 
A in a background where the levels of CDT1 are constitutively upregulated by 
derepression of E2F-dependent transcription may lead to induction of 
rereplication and possibly genomic instability. To mimic our ∆nrm1 yeast 
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model in RPE immortalised human cells we depleted cells for E2F6 and 
E2F7 by means of siRNA and measured the protein levels of CDT1 and 
Cyclin A. Preliminary data indicates that as expected, CDT1 and Cyclin A are 
upregulated in RPE cells following treatment with siRNA directed against 
E2F6 and E2F7 (Figure 4.17).   
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5. Miscellaneous     
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5.1  –  Yox1p  and  Nrm1p  interact  with  each  other  to  repress  MBF 
transcription 
The MBF is composed of two DNA-binding proteins, Res1p and Res2p and 
the product of the START gene Cdc10p (Aligianni et al., 2009). Furthermore, 
it has been shown that transcriptional repression of MBF involves the 
coordinated action of two co-repressors, Nrm1p and Yox1p, which are bound 
to chromatin throughout G2 and M phases of the cell cycle and are released 
from MBF-dependent genes upon entry into G1 and treatment with HU. 
Recent studies suggest that Yox1p associates directly or indirectly with the 
Cdc10p and Res2p components of the MBF complex (Aligianni et al., 2009) 
but nothing is known about the interactions between Nrm1p and Yox1p. To 
determine if Yox1p physically interacts with Nrm1p we carried out myc-
targeted immunoprecipitations in wild type strains carrying Yox1-3HA-tagged 
and Nmr1-13myc-tagged versions of these two proteins and blot membranes 
for HA and Myc. We establish that Yox1p and Nrm1p associate with each 
other in wild type cells as depicted in Figure 5.1. This interaction seems to be 
independent of inactivation of res2+, as deletion of res2+ does not abolish the 
interaction verified between Nrm1p and Yox1p (Caetano et al., 2011). It has 
also been observed that Yox1p does not bind detectably to MBF promoters 
in the absence of nrm1+ (nrm1Δ cells), suggesting that Nrm1p may function 
as a scaffold for Yox1p binding to MBF promoters.   
 
Figure 5.1 – Yox1p and Nrm1p co-immunoprecipitate 
Wild type cells carrying Nrm1p-13myc and Yox1p-3HA were allowed to grow for 4 
hours. Lysates were enriched for myc and membranes tagged for both myc and HA.   
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5.2 – Deleting yox1+  induces overexpression of Nrm1p at the protein 
level 
Deleting either nrm1+ or yox1+ results in upregulation of MBF transcripts. As 
we saw before this leads to accumulation of Cdc18p and Cig2p at protein 
levels. We have also looked at the protein levels of Nmr1p in Δyox1 cells and 
as expected we see a hyperaccumulation of Nrm1p in these cells (Figure 
5.2). Although Δyox1 cells accumulate Nrm1p at higher levels than in wild 
type cells they are still unable to repress MBF transcription, suggesting that 
nrm1+ requires yox1+ for proper repression of G1/S transcripts and vice 
versa.  
                     
Figure 5.2 – Nrm1p accumulates in Δyox1 mutant cells 
Western blot analysis of the protein levels of Nrm1p in wild type and Δyox1 cells. 
Nmr1p was tagged with HA and detected with anti-HA antibodies as described in 
section 2.3.3.  
  106 
5.3 – Genetic interaction of Δnrm1 with cdc25‐22 
Temperature sensitive cdc25-22 cells are known to arrest at G2 phase of the 
cell cycle, when grown at non-permissive temperatures (37°C). Cdc25p 
dephosphorylates Cdc2p/Cdk1p at Tyr15, to render it active and allow cells 
to progress into mitosis. Wee1p largely counteracts this reaction by 
phosphorylating Cdc2p at the same residue, thus, preventing entry into 
mitosis. In an attempt to study the levels of MBF transcription in synchronous 
∆nrm1 cells via the Cdc25-22 block and release method we have crossed 
∆nrm1 cells with cdc25-22 mutants and subjected the obtained asci to tetrad 
analysis. To our surprise, we have observed that ∆nrm1cdc25-22 mutant 
cells are synthetic lethal and unable to grow at permissive temperatures 
(Figure 5.3).  
 
Figure 5.3 – Crossing Δnrm1 with cdc25-22 mutants gives rise to synthetic lethal 
mutants  
Haploid ∆nrm1 cells were crossed with cdc25-22 cells and the generated spores 
dissected as described in section 2.1.5. Experiments were repeated at least three 
times and all crosses gave rise to synthetic lethal double mutants.     
Nuclear staining of these cells revealed a highly elongated phenotype and 
scattered DNA, possibly due to chromosome missegregation (Figure 5.4). 
We hypothesise that the synthetic lethality observed for ∆nrm1cdc25-22 is 
due to the inability of ∆nrm1 cells to progress into mitosis and that prolonged 
G2 phase may result in the accumulation of further DNA damage in these 
cells. Alternatively it is possible that, given the role of Cdc25p in activating 
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Cdc2p, Cdc2p is no longer accessible to target Cdc18p for proteolysis 
together with Cig2p.     
 
Figure 5.4 –  Δnrm1cdc25-22 double mutants are highly elongated and present 
scattered DNA  
Fluorescent microphotographs of ∆nrm1cdc25-22 synthetic mutants showing 
scattered DNA at both permissive and non-permissive temperatures.   
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6. Discussion 
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6.1 – Objective 1 ‐ Discussion  
In order to properly replicate their DNA and avoid genomic instability, cells 
utilize the DNA replication and the DNA damage checkpoints. The DNA 
replication checkpoint is mediated via the Rad3p-Cds1p signal transduction 
pathway, which is activated in the presence of DNA replication stress 
(Lindsay et al., 1998) (Xu et al., 2006) (Xu and Kelly, 2009). An important 
feature of the DNA replication checkpoint response consists of the activation 
and maintenance of the regular cell-cycle dependent MBF transcriptional 
programme (Dutta et al., 2008) (Dutta and Rhind, 2009) (de Bruin et al., 
2008) (Chu et al., 2007) (Chu et al., 2009) (Caetano et al., 2011). The 
inability to do so, as observed in cells lacking the checkpoint protein kinases 
Rad3p and Cds1p, results in extreme sensitivity to agents that promote loss 
of integrity of the replication fork, such as HU and MMS (Murakami and 
Okayama, 1995). In S. pombe and during normal cell cycle progression, MBF 
transcription is regulated by a double negative feedback loop involving the 
actions of the co-repressors Nrm1p and Yox1p (de Bruin et al., 2008) 
(Aligianni et al., 2009).  
 
Figure 6.1 – Regulation of Yox1p in response to HU-dependent checkpoint 
activation 
Activation of the DNA replication checkpoint and maintenance of the MBF 
transcriptional programme following HU challenge occurs via phosphorylation and 
inactivation of both Nrm1p and Yox1p by the DNA replication checkpoint effector 
kinase Cds1. 
In this report we have shown that, as observed for Nrm1p, inactivation of 
Yox1p and its dissociation from MBF promoters is necessary for full de-
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repression of MBF transcripts, following HU-induced activation of the DNA 
replication checkpoint. Treatment with HU promotes loss of Yox1p from MBF 
at promoters (Figure 3.1). This correlates with maintenance of high levels of 
expression of the MBF transcriptional programme, which amongst others 
includes enzymes involved in the production of dNTPs (cdc22+) and the 
licensing factors cdc18+ and cdt1+ (Figure 3.2) (Caetano et al., 2011). In line 
with this, inactivation of yox1+ makes DNA replication checkpoint ∆cds1 
mutants less sensitive to the deleterious effects of HU and MMS, indicating 
that de-repression of MBF-dependent transcripts is a crucial step for viability 
of cells undergoing replicative stress (Figure 3.5). Furthermore, we have 
shown that inactivation of Yox1p is Cds1p-dependent, and that 
phosphorylation at residues Ser114 and Thr115 plays an important role in 
the activation of checkpoint-dependent MBF transcription (Figure 3.6).  
Although the yox12A mutation prevents Yox1p phosphorylation at the RRKST 
locus, which significantly reduces the induction of MBF-dependent transcripts 
following activation of the DNA replication checkpoint, it does not result in 
increased sensitivity to HU and MMS (Figure 3.6). In addition, mutating a 
combination of checkpoint-dependent phosphorylation sites in nrm18A and 
cdc108A result in a partial loss of induction of MBF transcription following HU 
treatment, but cells do not present a higher sensitivity to the same drug (data 
not shown). Furthermore, no difference in HU sensitivity, when compared to 
wt cells, is observed for the combination of the cdc108A mutant with the 
yox12A mutant (data not shown). Based on this we hypothesise that a triple 
crm18A yox12A cdc108A mutant may be required for complete abrogation of 
the checkpoint-dependent MBF transcriptional response. To answer this 
question a strain carrying the referred triple mutant should be produced and 
checked for sensitivity to HU. It could also be assessed whether reduced 
levels of MBF-dependent transcription following activation of the checkpoint 
occur in this triple-mutant strain as observed in our yox12A mutant. 
Furthermore, this strain could be tagged with Rad22p-YFP, a marker for DNA 
damage, treated with HU and quantified for Rad22 foci number to determine 
if these cells experience more genomic instability, when treated with HU, 
than their wild type counterparts. 
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Recently, two studies have been published with similar findings to the ones 
described here. These suggest, as described in this report, that Yox1p is a 
direct target of the DNA replication checkpoint effector kinase Cds1p, and 
that this reaction is necessary for derepression of the MBF transcriptional 
response following HU-induced DNA replication stress (Gómez-Escoda et 
al., 2011) (Purtill et al., 2011). In addition to the findings reported here, it is 
also demonstrated that Yox1p is a target of CDK activity. In vitro kinase 
assays have shown that Yox1p is phosphorylated by Cdc2p-Cdc13p at 
residue Ser6. Substitution of Ser6 into an alanine residue completely 
abolishes the Cdc2p-Cdc13p-mediated phosphorylation of Yox1p, however 
no in vivo effects of loss of Ser6 phosphorylation have been found (Gómez-
Escoda et al., 2011). The biological importance of this reaction remains 
obscure.  
Yox1p and Nrm1p are involved in a negative feedback loop to confine G1/S 
transcription to the G1-phase of the cell cycle. As we saw in section 4, 
genetic perturbation of either nrm1+ or yox1+ leads to increased MBF-
dependent transcription indicating that both proteins are required, but are not 
sufficient, to repress MBF transcription outside of G1 phase. One can argue 
that this creates a less robust system to repress transcription, since 
mutations that affect either Yox1p or Nrm1p will result in loss of cell cycle 
regulated transcription. Based on the same argument the use of two non-
redundant proteins creates a more robust regulatory system when MBF-
dependent transcription needs to be de-repressed outside of normal G1 
phase (e.g. following activation of the DNA replication checkpoint). So why 
use two non-redundant proteins to repress transcription during the cell cycle? 
Here we show that in response to DNA replication stress the DNA replication 
checkpoint de-represses MBF-dependent transcription by releasing both 
Yox1p and Nrm1p from MBF at promoters (Figure 7.1). So whereas confining 
MBF-dependent transcription to the G1 phase of the cell cycle is not 
essential in rapidly growing cells, as ∆nrm1 and ∆yox1 deletion mutants are 
viable, we show that de-repression of MBF-dependent transcription is 
essential in response to genotoxic stress. Overall the requirement for these 
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multiple, non-redundant negative feedback loops is striking and may reflect 
the importance of keeping transcription ON in response to genotoxic stress 
over turning transcription OFF outside of G1. In addition, by targeting an 
autoinhibitory negative feedback loop the checkpoint ensures that once the 
replication stress is dealt with MBF transcription is switched OFF 
immediately. Whilst cells deal with DNA replication stress, Cds1p keeps 
MBF-dependent transcription active via phosphorylation of Nrm1p and 
Yox1p, which, being MBF targets themselves start to hyperaccumulate. Once 
replication stress terminates, Cds1p is made inactive and accumulated 
Nrm1p and Yox1p are free to bind to promptly turn OFF G1/S transcription.  
Work from the de Bruin lab has shown that, although there is no sequence 
homology between the mammalian G1/S transcription factors, the E2F 
family, and the yeasts MBF and SBF, the mechanism by which cells activate 
DNA replication checkpoint-dependent G1/S transcription is conserved from 
yeast to humans. As observed for S. pombe and S. cerevisiae, in human 
cells, treatment with HU results in maintenance at high levels of expression 
of the G1/S transcriptional programme. This is mediated by CHK1-dependent 
phosphorylation, and inactivation of the E2F repressor E2F6, much like the 
Cds1p-dependent inactivation of Nrm1p and Yox1p in fission yeast. Like 
Nrm1p and Yox1p, E2F6 is a G1/S transcript, which is involved in a negative 
feedback loop to repress transcription when cells progress into S phase. In 
response to replication stress Chk1 directly phosphorylates E2F6 resulting in 
its dissociation from E2F promoters (unpublished data). The conservation of 
this regulation and the mechanism by which it is implemented demonstrates 
the importance of G1/S transcriptional induction for the survival of cells 
undergoing DNA replication stress and highlights the significance of this 
particular mechanism of regulation that allows induction during the 
checkpoint response and rapid repression once satisfied.   
Following DNA replication stress the same transcriptional programme is 
maintained at high levels of expression (Chu et al., 2007) (Dutta et al., 2008) 
(Caetano et al., 2011). The reason why this happens remains unresolved but 
is likely to relate to the function of the transcripts regulated by MBF. Many 
MBF-dependent transcripts are known to have a role in the DNA checkpoint 
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response. These include, but are not limited to mik1+, a kinase that inhibits 
mitosis, mrc1+; the Cds1p mediator in the DNA replication checkpoint 
pathway; ssb1+, an RPA ssDNA-binding protein; ctp1+, a subunit of the 
MRN complex; rhp51+, a Rad51p recombinase; and the repair helicase 
pfh1+ (Dutta et al., 2008). Although some MBF transcripts do not have an 
obvious function in the DNA replication checkpoint response, it may be that 
their activities are required for later events. For example cdc22+, which 
encodes the large subunit of ribonucleotide reductase involved in the 
synthesis of ribonucleotides and the licensing factors cdc18+ and cdt1+, may 
be required for restarting of stalled DNA replication.  Furthermore, Cdc18p 
has also been implicated in the generation and maintenance of intermediate 
replication structures necessary for DNA replication checkpoint activation 
(Liu et al., 2000) (Murakami et al., 2002).   
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6.2 – Objective 2 ‐ Discussion  
Activation of G1/S transcription initiates the G1-to-S transition and commits 
cells to a new cell cycle. In S. pombe the G1/S transcriptional wave is 
controlled by the transcription factor MBF. In mammalian cells G1/S cell-
cycle-regulated transcription is under the control of a large family of 
transcription factors collectively known as the E2F transcription factors, 
which are regulated by the pocket proteins, the tumour suppressor pRB and 
p107 and p130 (Polager and Ginsberg, 2008). Uncontrolled cell growth is an 
invariable characteristic of human cancer. Constitutive activation of E2F-
dependent transcription, found in every type of cancer, allows cancer cells to 
sustain proliferation in the absence of growth factors and renders them 
insensitive to growth-inhibitory signals. (Chen et al., 2009). However, it has 
been postulated that there are alternative tumour-promoting activities for the 
E2F family, which are independent of cell cycle regulation. Here we have 
used the model organism S. pombe to study the effects of keeping G1/S 
transcription ON throughout all stages of the cell cycle. Since S. pombe cells 
spend little to no time in G1 and have, virtually, no G1-to-S transition control 
during an unperturbed mitotic cell cycle we could study the effect of de-
repressing G1/S transcription independent of its role in cell cycle regulation. 
Our work establishes that in addition to its effect on cell cycle progression de-
repression of G1/S transcription also induces sporadic rereplication and 
thereby actively contributes to the accumulation of genomic instability, 
another hallmark of cancer. 
In this report we confirm that fission yeast cells abrogated for nrm1+ or yox1+ 
show constitutive overexpression of MBF-dependent transcripts throughout 
the cell cycle (Figure 4.1) (de Bruin et al., 2006) (de Bruin et al., 2008) 
(Aligianni et al., 2009). We show that constitutive mRNA overexpression is 
reflected downstream in the protein level as confirmed by accumulation of 
Cdc18p and Cig2p in nrm1+ deletion mutants and Nrm1p in Δyox1 cells 
(Figure 4.8 and 5.2). nrm1+ and yox1+ deletion mutants are viable, however, 
they display a large variation in cell cycle length and are more elongated than 
their wt counterparts, a phenotype often linked with delay in S and/or G2 
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phases (de Bruin et al, 2008; Aligianni et al, 2009). We have shown that this 
cell cycle delay occurs due to activation of the DNA damage checkpoint as 
abrogation of the DNA damage checkpoint effector protein kinase chk1+ in a 
∆nrm1 background partially rescues the elongation phenotype observed for 
the ∆nrm1 cells, respectively. The same was observed for deletion of the 
upstream checkpoint protein kinase rad3+ in a ∆nrm1 background (data not 
shown).  
Our results indicate that activation of MBF-dependent transcription, by 
deletion of the MBF co-repressors nrm1+ or yox1+ or the repressor res2+, 
promotes accumulation of Rad22 foci, a marker for single stranded DNA 
(ssDNA), indicative of DSBs, presence of collapsed or stalled DNA 
replication forks and persistent recombination intermediates (Kim et al., 
2000). Based on these observations we speculate that de-repression of 
MBF-dependent transcripts outside of G1/S phases results in DNA damage 
accruement and genomic instability, both hallmarks of cancer aetiology. In 
agreement with this, ∆nrm1, ∆yox1 and ∆nrm1∆yox1 cell populations present 
higher levels of cells with aberrational morphologic phenotypes than their 
wild type counterparts. Several classes of aberrant cell morphology 
phenotypes have been observed including cells with scattered DNA, cut 
phenotype and chitin accumulation, the last being an indicator of 
compromised cytokinesis.  
Cells prevent rereplication by allowing DNA replication origins to be licensed, 
via binding of licensing factors, when there is no CDK activity at the end of 
mitosis and beginning of G1 (Tanaka and Araki, 2010). In addition licensing 
factors accumulate solely during G1, limiting licensing activity to the end of 
mitosis. This further ensures that replication happens once and only once per 
cell cycle. However, overexpression of licensing factors has been shown to 
bypass this failsafe mechanism by licensing origins even in the presence of 
CDK activity and absence of mitosis, causing rereplication, demonstrating 
that accurate control of Cdc18p and Cdt1p activities is required at all times in 
the cell cycle, in order to prevent rereplication (Jallepalli et al., 1997). 
Inactivation of nrm1+ and yox1+ leads, amongst others, to overexpression of 
the replication initiation factors cdc18+ and cdt1+ and the S-phase cyclin 
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cig2+ both at the transcription and at the protein levels (Figure 4.1 and Figure 
4.8). Whereas overexpression of Cdc18p alone has been shown to induce 
rereplication (Jallepalli et al., 1997) (Lopez-Girona et al., 1998), our work 
shows that simultaneous overexpression of the CDK cyclin Cig2p largely 
counteracts this. We show that the number of Rad22 foci is slightly lower 
than the number of Rad22 foci observed for ∆nrm1 cells alone when cig2+ is 
further induced and significantly higher when cig2+ is repressed. 
Furthermore, deletion of cig2+ in a ∆nrm1 background promotes formation of 
further genomic instability compared to genomic instability measured for 
∆nrm1 single mutants. Cig2p is known to target Cdc18p for proteolysis via 
the ubiquitin E3 ligase Cullin F-box containing complex (SCF) in a CDK-
dependent manner (Lopez-Girona et al., 1998). Hence, since both licensing 
factors and cyclin Cig2p are G1/S transcripts, derepression of G1/S 
transcription results in a delicate balance of high levels of licensing factors 
and CDK activity, which cause only sporadic rereplication but a significant 
increase in genomic instability, as determined by formation of Rad22 foci and 
aberrant morphological defects in ∆nrm1 and ∆yox1 cells (Figure 7.2). 
Disruption of this delicate balance by means of downregulating CDK activity 
results in formation of further genomic instability, as ∆nrm1∆cig2 and 
thiamine-treated P41nmt1cig2 ∆nrm1 cells are extremely sick and present 
very high numbers of Rad22 foci (Figure 4.7 and 4.14).  To establish whether 
this is the result of hyper-accumulation of Cdc18p, levels of Cdc18p in 
∆nrm1∆cig2 and in thiamine-treated P41nmt1cig2 ∆nrm1 cells should be 
determined. We hypothesise that the protein levels of Cdc18p hyper-
accumulate in these cells compared to ∆nrm1 alone, due to a disruption in 
the ability to target Cdc18p for proteolysis via the Cig2-CDK pathway.   
Our data suggests that the genomic instability observed in ∆nrm1, ∆yox1 and 
∆nrm1∆yox1 cells is largely due to hyperaccumulation of Cdc18p (Jallepalli 
et al., 1997) (Lopez-Girona et al., 1998). However, given the relatively large 
number of genes regulated by MBF, it is possible that other MBF transcripts 
may also contribute to the generation of the genomic instability encountered. 
In order to explore the contribution of cdc18+ to the generation of genomic 
instability in our ∆nrm1 cells, a strain bearing an inducible nmt1-cdc18 
promoter should be constructed, crossed with ∆nrm1 cells and the number of 
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Rad22 foci quantified following repression of cdc18+ with thiamine. However, 
since cdc18+ is both an essential and a dosage sensitive gene (constitutive 
expression causes rereplication) it can’t be overexpressed or repressed 
beyond certain levels, which might be tricky. Alternatively, the expression of 
cdc18+ could be placed under the control of an MBF-independent cell cycle 
regulated promoter in an ∆nrm1 background. Candidate promoters could be 
those regulated by the M/G1 cell cycle transcription factor, Ace2, given that 
their expression pattern is quite close to that of the MBF transcriptional wave 
(Bähler, 2005). In an ∆nrm1 mutant this would reconstitute the cyclical 
expression pattern of cdc18+ while the remaining MBF genes are maintained 
a high levels. If the number of Rad22 foci generated in these strains was to 
be close to wild type levels then we could conclude that accumulation of 
Cdc18p is in fact the main reason why nrm1+ mutant cells display elevated 
levels of genomic instability. If the number of Rad22 foci generated was 
similar to or only slightly lower than ∆nrm1 cells but higher than wild type 
cells we would conclude that other genes contribute to Rad22 focus 
accumulation when constitutively expressed. These could include, but are 
not limited to, the RNR subunits cdc22+ and suc22+, which are required for 
dNTP synthesis; the translesion polymerase polκ+; and ctp1+, a protein 
involved in homologous recombination (HR). Elevated dNTP pools are 
known to induce genomic instability likely by allowing error prone replicative 
DNA polymerases to bypass certain DNA lesions (Sabouri et al., 2008). In 
the yeast S. cerevisiae, upregulation of the RNR subunit induces an increase 
in the copy number of mtDNA (Xu et al., 2008). In mice altered RNR 
expression promotes lung carcinogenesis and increases the metastic 
potential (Fan et al., 1996) (Xu et al., 2008). Hyperaccumulation of 
translesion polymerases such as polκ+ was reported to allow these error-
prone polymerases to access undamaged DNA and increase untargeted 
mutagenesis (Rattray and Strathern, 2003). Finally increased ctp1+ levels 
may lead to over-induction of homologous recombination repair (Limbo et al 
2007, Mol Cell).   
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The role of genomic instability in cancer development remains poorly 
understood. The most accepted view on cancer aetiology relies on the 
mutator hypothesis, whereby genomic instability (e.g. chromosomal instability 
and microsatellite instability), which is believed to be present in most 
precancerous lesions, drives formation of neoplasia by increasing the rate of 
spontaneous mutations (Negrini et al., 2010). According to this theory 
increase in the spontaneous mutation rate occurs early in cancer 
development and it leads to emergence of mutations in classical caretaker 
genes such as DNA repair genes and mitotic checkpoint genes (e.g. TP53 
and ATM). Although this has been shown to be involved in the formation of 
hereditary cancers, wide genome analyses have failed to demonstrate the 
same to be true for the formation of sporadic human cancers, as mutations in 
caretaker genes seem to be infrequent amongst this class of tumours. This 
led to the formulation of an alternative model, the oncogene-induced DNA 
replication stress model (Halazonetis et al., 2008). According to the 
oncogene-induced DNA replication model activation of oncogenes leads to 
the establishment of DNA damage and DNA replication stress, which in turn 
drive formation of tumours. In this report we show that the G1/S 
transcriptional programme has an important role in response to replicative 
stress and that de-repression of G1/S transcription contributes to the 
formation of genome instability via the misregulation of DNA replication.  
Understanding how unregulated G1/S transcription and DNA replication 
stress contribute to the generation of genomic instability is becoming 
increasingly important in cancer biology. In mammalian cells G1/S 
transcription is turned off in S phase by the E2F repressors E2F6 and E2F7, 
much like Nrm1 and Yox1 in fission yeast. Our preliminary data shows that 
knocking down either E2F6 or E2F7 in RPE cells induces the accumulation 
of licensing factors CDT1 and CDC6 (cdc18 in S. pombe) and cyclins E and 
A (Cig2 in S. pombe) at the protein level, much like that observed in fission 
yeast (Figure 4.17). In mammalian cells cyclin A is involved in the 
degradation of CDT1. Future work should focus on determining if co-
downregulating E2F6/7 and cyclin A, therefore creating an unbalance 
between licensing factors and CDK activity, leads to formation of bulk 
genomic instability in RPE cells, as verified for fission yeast. Given the role of 
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Geminin in degrading CDT1, in mammalian cells, co-downregulation of E2F6 
and geminin could also be tested for generation of further genomic instability. 
If the lethal synergy observed between ∆nrm1 and ∆cig2 cells in fission yeast 
is conserved in RPE cells, E2F6/7 and cyclin A could represent two potential 
therapeutic targets for the treatment of cancer. 
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Figure 6.2 – Model 
(Wild type cells) Cdc18p and Cdt1p are involved in loading the MCM helicase onto 
origins of replication during a step known as origin licensing. In order to prevent re-
rereplication, Cdc18p is sent for proteolysis via the Cig-CDK pathway, thus inhibiting 
re-licensing of already fired origins. (Δnrm1 cells) Deletion of nrm1+ promotes 
upregulation of both Cdc18p and Cig2p, resulting in a delicate balance between 
licensing factors and CDK activity, hence, between licensing activation and licensing 
inhibition. This results in accumulation of genomic instability and sporadic 
rereplication. (Δnrm1Δcig2) Disruption of this balance by abrogation of Cig2p-CDK 
activity results in enhanced licensing activation, hence, further accumulation of 
genomic instability and rereplication. 
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